gene

By increasing SBG1 protein activity in plants, suberin deposition is enhanced, addressing the genetic limitations of root protection and carbon storage, thereby improving stress tolerance and agronomic traits in crops.

WO2026234013A1PCT designated stage Publication Date: 2026-11-12UNIVERSITY OF GENEVA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2026/062962
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-20
Filing Date
2026-05-05
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

The genetic basis for regulating suberin deposition in plant roots remains poorly understood, limiting the ability to enhance root suberin as a protective barrier against environmental stresses and carbon storage.

Method used

Increasing the level or activity of the SUBER GENE 1 (SBG1) protein or its homologs/orthologs in plants, particularly through interaction with Type One Protein Phosphatases (TOPPs), enhances suberin deposition in plant roots.

Benefits of technology

This approach increases root suberization, improving stress tolerance and carbon storage capabilities in agricultural crops without requiring agrochemical inputs, enhancing drought, salt stress, and nutrient deficiency resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000022_0001_TABLE
    Figure IMGF000022_0001_TABLE
  • Figure IMGF000023_0001_TABLE
    Figure IMGF000023_0001_TABLE
  • Figure IMGF000023_0002_TABLE
    Figure IMGF000023_0002_TABLE
Patent Text Reader

Abstract

The present invention relates to a method of increasing suberin deposition in plant roots. The present invention also relates to polynucleotides encoding SBG1 (SUBER GENE 1) proteins as well as homologs ortholog thereof, in addition to vectors, cells, plants, and plant parts comprising said polynucleotides.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] GENE

[0002] FIELD OF THE INVENTION

[0003] The present invention relates to a method of increasing suberin deposition in plant roots. The present invention also relates to polynucleotides encoding SBG1 (SUBER GENE 1) proteins as well as homologs ortholog thereof, in addition to vectors, cells, plants, and plant parts comprising said polynucleotides.

[0004] BACKGROUND OF THE INVENTION

[0005] Plant roots serve as the primary interface between plants and the soil, playing a critical role in nutrient acquisition and water uptake.

[0006] To regulate the movement of water, ions, and nutrients, plant roots have evolved complex anatomical structures, including the deposition of suberin in the root endodermis. Suberin is a hydrophobic biopolymer which forms selective barrier that controls radial transport, as well as providing plants with protection from environmental stresses such as drought, salinity, nutrient imbalances, and pathogens1. Increasing suberin deposition in roots also has the potential to contribute to underground carbon storage.

[0007] The pattern of suberin deposition in the root endodermis is precisely regulated during root development. In Arabidopsis thaliana. endodermal differentiation progresses through distinct stages. First, Casparian strips (CS) form an apoplastic barrier (non-suberized region) in the endodermis. Following this, patches of endodermal cells undergo suberization (known as patchy suberization zone), where suberin is selectively deposited. Eventually, the entire endodermal layer becomes uniformly suberized (suberized zone).

[0008] At the molecular level, the pattern of endodermal suberization is a highly regulated process, orchestrated by the interplay of several hormones and signalling pathways. In particular, abscisic acid (ABA) signalling plays a crucial role in suberin formation during development and in response to stress. CASPARIAN STRIP INTEGRITY FACTOR (CIF) peptides also play crucial role in regulating the integrity and proper function of CS by reinforcing endodermal barriers via interaction with Leucine-Rich Repeat Receptor-Like Kinase SGN3 / GSO1 (SCHENGEN3 / GASSHO1) independently of ABA.

[0009] Despite considerable progress in identifying the molecular players involved in suberin biosynthesis and regulation, the genetic basis for the regulation of suberin deposition in plants remains poorly understood.

[0010] SUMMARY OF THE INVENTION

[0011] The present invention relates to a method of increasing suberin deposition in the root of a plant.

[0012] The inventors have surprisingly found that increasing the level or activity of a SUBER GENE 1 (SBG1) protein increases suberin deposition in plant roots. In particular, increasing the level or activity of an SBG1 protein in Col-0 A. thaliana plants using a constitutive promoter results in a significant increase in root suberization compared to control plants.

[0013] In view of suberin’s critical role as a protective barrier in roots against drought and pathogens, as well as its potential to contribute to underground carbon storage, increasing thelevel or activity of SBG1 or a homolog or ortholog thereof in agricultural crops could facilitate significant improvements in a number of key agronomic traits. Increasing the level or activity of SBG1 protein or a homolog or ortholog thereof in a plant in accordance with the invention is particularly advantageous because it overcomes natural limits to increasing root suberin deposition and fitness without requiring agrochemical inputs. For instance, increasing the level or activity of SBG1 protein or a homolog or ortholog thereof in maize (Zea mays), rice (Oryza saliva), common grape vine (Vitis vinifera), or tomato (Solarium lycopersicum) by increasing expression of a native gene, or transforming said plants with a heterologous gene under the control of a constitutive promoter, could increase the tolerance of these important agricultural crops to various stresses including, but not limited to, salt stress, nutrient deficiency stress, and / or drought stress.

[0014] The present invention accordingly provides a method of increasing suberin deposition in the root of a plant by increasing the level or activity of an SBG1 protein or a homolog or ortholog thereof. The invention also provides a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof. The invention also provides a vector comprising a polynucleotide in accordance with the invention. The invention also provides a cell comprising a polynucleotide or vector according to the invention. The invention also provides a plant or part thereof comprising a polynucleotide, vector, or cell according to the invention. The invention also provides uses of polynucleotides, vectors, and cells according to the invention in methods of increasing suberin deposition in plant roots. The invention also provides a method of producing a plant having increased suberin deposition. The invention also provides a method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention. The invention also provides plants or plant cells obtained according to the method of the invention.

[0015] DESCRIPTION OF THE FIGURES

[0016] Figure 1 shows the natural variation in suberin deposition among Arabidopsis thaliana accessions.

[0017] Quantification of suberin deposition in 4-day-old roots of 284 Arabidopsis accessions using fluorol yellow staining. Accessions are sorted by the percentage of suberized zone. Data are presented as stacked columns showing the mean percentage of each suberization zone + s.d., n > 10.

[0018] Figure 2 shows the identification of SBG1 as a genetic determinant of variation in suberization.

[0019] (a) Manhattan plot of GWAS for suberin variations across 265 Arabidopsis thaliana accessions. Horizontal dashed lines indicate significant thresholds after multiple testing correction: red for Bonferroni and blue for Benjamini-Hochberg (FDR = 10%).

[0020] (b) SNPs and annotated genes surrounding the SBG1 genomic region. Each dot represents a SNP, with the top SNP highlighted in red.

[0021] (c) Suberin deposition pattern in T-DNA insertion lines for candidate genes shown in (b). Data are presented as stacked columns showing the mean percentage of each suberization zone + s.d., n = 10. One-way ANOVA followed by a Tukey’s test was used to assess significance for the suberized zone; different letters indicate significant differences between genotypes (P < 0.05).

[0022] (d) Whole-mount images of fluorol yellow-stained roots from Col-0 and sbgl-1 shown in (c). Red arrows indicate the onset of suberized zone; white lines mark the root tip. Scale bar, 1 mm.(e)-(f), Suberin deposition pattern in sbgl mutants generated in Leo-1 (e) and Tsu-0 (f) backgrounds. Data are presented as in (c), n = 10. One-way ANOVA followed by a Tukey’s test was used to test significance in the suberized zone (P < 0.05).

[0023] (g) SNP profiles in the SBG1 genomic region across 3 T and 3 G allele accessions. T and G alleles are shown in blue and pink respectively. The top SNP from GW As is marked with a red arrow. SNP data were obtained from the 1001 Genomes dataset.

[0024] (h)-(j), Suberin deposition pattern in transgenic lines expressing SBG1 under the UBQ10 promoter in the background of Lm-2 (h), Nc-1 (i) and Litva (j). SBG1 genomic sequence including 1.5 kb downstream of the stop codon was derived from Lm-2, Nc-1, Litva, Sf-2, Shigu-1 or Tsu-0 as indicated. Two independent lines were analyzed per construct. Data are presented as in (c). One-way ANOVA followed by a Tukey’s test was used to determine significance in the suberized zone (P < 0.05).

[0025] Figure 3 shows the regulation of suberization by SBGL

[0026] (a)-(b) Whole-mount images of fluorol yellow-stained roots (a) and suberin deposition pattern (b) in sbgl mutants and complemented lines. Red arrows indicate the onset of suberized zone; white lines mark the root tip. Scale bar, 1 mm. Data are presented as stacked columns showing the mean percentage of each suberization zone + s.d., n = 10. One-way ANOVA followed by a Tukey’s test was used to assess significance for the suberized zone; different letters indicate significant differences between genotypes (P < 0.05).

[0027] (c)-(d) Whole-mount images (c) and quantification (d) of suberin deposition in transgenic lines expressing SBGl-mVenus under the UBQ10 promoter. Data are presented as in (a,b).

[0028] (e)-(f), Quantification of ester-bound aliphatic and aromatic suberin monomers in 5 -day-old roots. FA, fatty acid; DCA, dicarboxylic fatty acid; co-OH, co-hydroxy fatty acid; DW, dry weight. Data are shown as histograms with individual values overlaid, s.d., n = 4. Two-way ANOVA followed by a Tukey’s test was used to assess significance for each suberin monomer, oxygenated and unsubstituted FA; different letters indicate significant differences between genotypes (P < 0.05).

[0029] (g) Confocal images of SBGl::NLS-3xmVenus line showing mVenus signal (green) combined with PI staining (magenta) to highlight cell walls. In the early and late differentiated roots mVenus signal was projected in 3D. Cross-section views were generated by re-slicing Z-stacks. Scale bar, 20 pm.

[0030] (h) Confocal images of SBGl::NLS-3xmVenus lines treated with or without 1 pM ABA for 18h. mVenus signal is shown in green and PI in magenta. White arrows indicate the onset of mVenus signal after the division zone. Scale bar, 500 pm.

[0031] (i)-(j) Whole-mount images (i) and suberin deposition pattern (j) in sbgl-1 and high-order sbgll mutants under control (mock) or 1 pM ABA treatment for 18h. 4-day-old seedlings were transferred to either ’A MS plates or ’A MS plate + ABA. Data are presented as in (a,b). Apostrophes and underlines indicate different statistical comparisons.

[0032] Figure 4 shows that mutations in SBG1 reduces root suberization in strong accessions.

[0033] (a) Frequency distribution of the fully suberized zone across 265 Arabidopsis accessions used for the GWAS shown in Figure 2a.

[0034] (b)-(c) Quantile-quantile (QQ) plots corresponding to the GWAS shown in the Manhattan plot in Figure 2a.

[0035] (d) SNPs located at positions 2,769,796 and 2,769,807 on Chromosome 4.

[0036] (e) Percentage of the suberized zone in accessions carrying the 2 alleles at SNP position 19,579,742 on Chromosome 1. Data are presented as box plots with outlier values overlaid.(f) qRT-PCR analysis of SBG1 relative transcript levels in roots of Col-0 and sbgl-1. Data are shown as violin plots with individual values overlaid, n = 3. A two-tailed Student’s t-test was performed, ***P < 0.001.

[0037] (g) Schematic showing the position of the T-DNA insertion in SBG1 in Col-0 and CRISPR-induced mutations in SBG1 generated in Leo-1 and Tsu-0 backgrounds.

[0038] (h)-(i) Whole-mount fluorol yellow-stained roots of sbgl mutants in Leo-1 and Tsu-0 backgrounds. Red arrows indicate the onset of the suberized zone; white lines mark the root tip. Scale bar, 1 mm.

[0039] Figure 5 shows the identification of TOPPs as targets of SBG1 proteins.

[0040] (a) Predicted AlphaFold structure of the SBG1 protein.

[0041] (b) Confocal images of SBGl-mVenus (green) in the SBG1 0X4 line with PI staining (magenta) to highlight cell walls. Scale bar, 20 pm.

[0042] (c) List of TOPP candidate interactors identified by IP -MS. Peptide quantification is shown for each protein, n = 3.

[0043] (d) Predicted AlphaFold structure of the SBG1 protein in complex with TOPP2. Cartoon representation colored by predicted local distance difference test (pLDDT) confidence scores.

[0044] (e) Predicted aligned error (PAE) plot corresponding to the AlphaFold model shown in (d).

[0045] (f) Aligned AlphaFold structures of SBG1 protein homologs in complex with TOPP2. Structural differences between SBG1 / SBG1L1 proteins and SBG1L2 / SBG1L3 proteins are observed at both N- and C- termini. The predicted AlphaFold structure of Inhibitor 2 (12) in complex with TOPP2 is shown on the right.

[0046] (g)-(h) Seed germination assay under ABA treatment. For each replicate 84 seeds per genotypes were sown on ’A MS or ’A MS supplemented with 1 pM ABA. Germination was scored after 96 hours. Data are shown as histograms with individual values overlaid, + s.d., n = 3. One-way ANOVA followed by Dunn’s test was used to assess differences between genotypes, n = 3.

[0047] (i) Suberin deposition pattern in topp mutants. Data are presented as stacked columns showing the mean percentage of each suberization zone + s.d., n= 10. One-way ANOVA followed by a Tukey’s test was used for the suberized zone to compare genotype. No significant difference was detected (P < 0.05).

[0048] Figure 6 shows SBG1 -mediated regulation of suberization via interactions with Type One Protein Phosphatases (TOPPs)

[0049] (a) Confocal images showing colocalization of SBGl-mCherry (magenta) with ER-GFP (cyan). Individual channels and merged images are shown Scale bar, 50 pm.

[0050] (b) Co-immunoprecipitation assay showing SBG1 interaction with TOPP2 in roots from plants co-expressing SBGl-mVenus and TOPP2-mScarletI or SBGl-mVenus and CYP86A1-mScarletl as a negative control.

[0051] (c) Predicted AlphaFold3 structure of the SBG1 protein in complex with TOPP2. The side chains of the SILK and RVxF motifs in SBG1 and two Mn2+ions in the catalytic domain of TOPP2 are highlighted.

[0052] (d) Schematic representation of mutations in the SBG1 protein binding motifs. SM denotes mutation in the RVxF motif, and DM denotes combined mutations in both the SILK and RVxF motifs. Mutation sites are marked with an “X”.(e) Yeast two-hybrid assay showing interactions between WT or mutated forms of SBG1 protein (SM and DM) and TOPP1 or TOPP2. Drop test started with OD600 of 0.01 followed by 10 times dilutions.

[0053] (f) Phosphatase activity assay showing SBG1 concentration-dependent inhibition of TOPP2 activity in vitro. Two-way ANOVA followed by Sidak’s test was used to assess the significance at each concentration (***p < 0.001, ns, not significant, n = 3).

[0054] (g) Whole-mount images of fluorol yellow-stained roots and corresponding suberin deposition pattern in sbgl, topp2 and sbgl / topp2 double mutants. Arrows indicate the onset of the suberized zone; white lines mark the root tip. Scale bar, 1 mm. In the accompanying chart, data are presented as stacked columns showing the mean percentage of each suberization zone + s.d., n = 11. Student’s t-test was used to assess significance between genotypes in the suberized zone (***P < 0.001). For multiple comparisons, one-way ANOVA followed by a Tukey’s test was used to assess significance for the suberized zone; different letters indicate significant differences between genotypes (P < 0.05).

[0055] (h) Confocal images of TOPP2: :NLS-3xmVenus in roots showing mVenus signal (green) overlaid with PI staining (magenta) to visualize cell walls. mVenus signal was projected in 3D. Cross-section views were generated by re-slicing Z-stacks. Scale bar, 50 pm.

[0056] (i) Whole-mount images (left) and suberin deposition pattern (right) in T1 overexpression lines expressing SBG1 SM and SBG1 DM compared to WT SBG1 (SBG1 OX4 and S). Data are presented as in (g). One-way ANOVA followed by Tukey’s test was used to assess significance in the suberized zone; different letters indicate significant differences between genotypes P < 0.05). n = 11 for Col-0 and SBG10X4 / 8, n = 20 for SBG1 SM OX (independent T1 lines), and n = 16 for SBG1 DM OX (independent T1 lines).

[0057] Figure 7 shows an alignment and phylogenetic analysis of SBG1 and its homologs.

[0058] (a) Schematic representation of the CRISPR-induced mutation in SBG1 to generate the sbgl-2 allele in the Col-0 background.

[0059] (b) Heat map of qRT-PCR analysis showing relative transcript levels of SBG1, GYP 86A1 / HORST, GPAT5 and MYB41 under control (Mock) or 1 pM ABA treatment for 3, 6, or 18h. Data presented as log2(fold change) relative to mock. Student’s t-test was used to assess significance between control and ABA treatments at each time point (*P < 0.05, n = 3).

[0060] (c) Schematic representation of CRISPR-induced mutations in SBG1L1, SBG1L2 and SBG1L3 to generate the sbgl-l;sbglll double mutant and the sbgl-1 ;sbglll ;sbgll2;sbgll3 quadruple mutants in the Col-0 background.

[0061] (d) Protein sequence alignment and phylogenetic analysis of SBG1, SBG1L1, SBG1L2 and SBG1L3 proteins. The SILK and RVxF motifs, known to mediate binding to TOPPs, are highlighted in pink and red respectively.

[0062] Figure 8 shows a phylogenetic analysis of SBG1 protein and its orthologs across a number of plant species.

[0063] (a) Protein sequence alignment of the SBG1 protein from A. thaliana and its orthologs from other 18 plant species. The sequences of SBGl’s orthologs were obtained by NCBI blast with highest similarity from each species. The SILK and RVxF motifs are highlighted in pink and red respectively.

[0064] (b) Phylogenetic analysis of the SBG1 protein from thaliana and its 18 orthologs with same protein sequence in (a). The scale bar indicates the branch lengths.Figure 9 shows a comparison of differentially expressed genes (DEG) from RNAseq in Col-0 and sbgl-1 roots after 2 pM ABA treatment for 4h. Heat maps showing the differential expression of ABA-induced marker genes, SBG1 and T0PP2 in Col-0 and sbgl-1 (*Padj < 0.05, ns, not significant, n = 3 pools of approximately 250 roots). GO enrichment analysis was performed for the 3028 unique DEGs in sbgl-1.

[0065] Figure 10 shows that SBG1 binds to and inhibits TOPP2 in vitro.

[0066] (a) An analytic gel-filtration assay demonstrating that only SBGI Col-O (but not SBG1 DM) binds to TOPP2. SDS-PAGEs showing the collected fractions of eluted peaks after gel filtration. Asterisks indicate the larger band which might be the dimer complex of SBG1 in all the samples.

[0067] (b) Aligned AlphaFold predicted structure of SBG1 from Col-0 and Tsu-0 in complex with TOPP2. Side chains in the differential sites are shown.

[0068] DETAILED DESCRIPTION OF THE INVENTION

[0069] The present invention will be described with respect to particular embodiments and with reference to certain drawings but the disclosure is not limited thereto but only by the claims.

[0070] Of course, it is to be understood that not necessarily all aspects or advantages may be achieved in accordance with any particular embodiment. Thus, those skilled in the art will recognize that the disclosed embodiments may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other aspects or advantages as may be taught or suggested herein.

[0071] Features, integers, or characteristics described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and / or all of the steps of any method so disclosed, may be combined in any combination, except combinations where at least some of such features and / or steps are mutually exclusive.

[0072] The invention is not restricted to the details of any of the following embodiments. The invention extends to any single feature, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel single feature, or any novel combination, of the steps of any method or process so disclosed. General Definitions

[0073] Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by a person skilled in the art to which this invention belongs.

[0074] The singular forms “a”, “an”, and “the” as used herein include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to “a polynucleotide” includes two or more polynucleotides, reference to “a protein” includes two or more proteins, and the like.

[0075] The terms “polynucleotide”, “nucleotide sequence”, and “DNA sequence” as used herein refer to a polymeric form of nucleotides of any length, which comprises ribonucleotides or deoxyribonucleotides. This term refers only to the primary structure of the molecule. Thus, this term includes double- and single-stranded DNA, and RNA. The term “polynucleotide” as used herein, may be a single or double stranded covalently-linked sequence of nucleotides inwhich the 3' and 5' ends on each nucleotide are joined by phosphodiester bonds. The polynucleotide may be made up of deoxyribonucleotide bases or ribonucleotide bases. Polynucleotides may be manufactured synthetically in vitro or isolated from natural sources. Polynucleotides may further include modified DNA or RNA, for example DNA or RNA that has been methylated, or RNA that has been subject to post-translational modification, for example 5 ’-capping with 7-methylguanosine, 3 ’-processing such as cleavage and polyadenylation, and splicing. Polynucleotides may also include synthetic nucleic acids (XNA), such as hexitol nucleic acid (HNA), cyclohexene nucleic acid (CeNA), threose nucleic acid (TNA), glycerol nucleic acid (GNA), locked nucleic acid (LNA) and peptide nucleic acid (PNA).

[0076] The term “amino acid” as used herein should be understood in its broadest sense and is meant to include organic compounds containing amine (NH2) and carboxyl (COOH) functional groups, along with a side chain (e.g., an R group) specific to each amino acid. In some embodiments, the amino acids refer to naturally occurring L a-amino acids or residues. The commonly used one and three letter abbreviations for naturally occurring amino acids are used herein: A=Ala; C=Cys; D=Asp; E=Glu; F=Phe; G=Gly; H=His; I=Ile; K=Lys; L=Leu; M=Met; N=Asn; P=Pro; Q=Gln; R=Arg; S=Ser; T=Thr; V=Val; W=Trp; and Y=Tyr. The general term “amino acid” further includes D-amino acids, retro-inverso amino acids as well as chemically modified amino acids such as amino acid analogues, naturally occurring amino acids that are not usually incorporated into proteins such as norleucine, and chemically synthesised compounds having properties known in the art to be characteristic of an amino acid, such as P-amino acids. For example, analogues or mimetics of phenylalanine or proline, which allow the same conformational restriction of the peptide compounds as do natural Phe or Pro, are included within the definition of amino acid. Such analogues and mimetics are referred to herein as "functional equivalents" of the respective amino acid.

[0077] The terms “polypeptide” and “peptide” are interchangeably used herein to refer to a polymer of amino acid residues and to variants and synthetic analogues of the same. Thus, these terms apply to amino acid polymers in which one or more amino acid residues is a synthetic non-naturally occurring amino acid, such as a chemical analogue of a corresponding naturally occurring amino acid, as well as to naturally-occurring amino acid polymers. Polypeptides can also undergo maturation or post-translational modification processes that may include, but are not limited to: glycosylation, proteolytic cleavage, lipidization, signal peptide cleavage, propeptide cleavage, phosphorylation, and such like. A peptide can be made using recombinant techniques, e.g., through the expression of a recombinant or synthetic polynucleotide.

[0078] The term “protein” is used to describe a folded polypeptide having a secondary or tertiary structure. The protein may be composed of a single polypeptide, or may comprise multiple polypeptides that are assembled to form a multimer. The multimer may be a homooligomer, or a heterooligomer. The protein may be a naturally occurring, or wild type protein, or a modified, or non-naturally, occurring protein. The protein may, for example, differ from a wild type protein by the addition, substitution or deletion of one or more amino acids.

[0079] The term “sequence identity” as used herein will be understood to arise from a comparison of two sequences in which they are aligned together to give a maximum correlation between the sequences. In order to determine the percentage identity of two sequences (such as two polynucleotide or two polypeptide sequences), the sequences are aligned for optimal comparison purposes (e.g. gaps can be introduced in a first sequence for optimal alignment with a second sequence). The nucleotide or amino acid residues at each position are then compared. When a position in the first sequence is occupied by the same amino acid as the corresponding position in the second sequence, then the amino acids are identical at that position. The percentidentity between the two sequences is a function of the number of identical positions shared by the sequences (i.e. % identity = number of identical positions / total number of positions in the reference sequence x 100).

[0080] Typically, the sequence comparison is carried out over the length of the reference sequence. For example, if the user wished to determine whether a given (“test”) sequence has at least 90% identity to SEQ ID NO: 1, SEQ ID NO: 1 would be the reference sequence. To assess whether a sequence has at least 90% identity to SEQ ID NO: 1 (an example of a reference sequence), the skilled person would carry out an alignment over the length of SEQ ID NO: 11, and identify how many positions in the test sequence were identical to those of SEQ ID NO: 1. If at least 90% of the positions are identical, the test sequence is at least 90% identical to SEQ ID NO: 1. If the sequence is shorter than SEQ ID NO: 1, the gaps or missing positions should be considered to be non-identical positions.

[0081] The skilled person is aware of different computer programs that are available to perform an alignment between two sequences. An alignment between two sequences can be accomplished using a mathematical algorithm. For example, an alignment may be performed using the Needleman and Wunsch algorithm (Needleman and Wunsch, 1970, J Mol Biol.;48(3):443- 53) which aligns the sequences optimally over the entire length). Sequences of substantially different lengths may alternatively be aligned using a local alignment algorithm (e.g. 15 Smith and Waterman algorithm (Smith and Waterman, 1981, JTheorBiol. ;91 (2):379-80) or Altschul algorithm (Altschul SF et al., 1997, Nucleic Acids Res.;25(17):3389-402; Altschul SF et al., 2005, Bioinformatics.;21(8):1451-6). Sequence identity may also be determined using homology comparison tools, including for example, the Basic Local Alignment Search Tool (BLAST) software of the National Center of Biotechnology Information (NCBI) and the CLUSTAL software of the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI). Those skilled in the art can determine appropriate parameters for measuring alignment, including any algorithms needed to achieve maximal alignment over the full length of the sequences being compared.

[0082] Unless otherwise indicated, polynucleotide sequences herein are written in the 5’-to-3’ direction from left to right.

[0083] SUBER GENE 1 (SBG1)

[0084] The terms “SUBER GENE 7” and “SBG1” as used herein refer to the gene locus AT1G5256 in the Arabidopsis thaliana genome. The terms “homolog” and “SBG1 homolog” as used herein refer to polynucleotide sequences within the Arabidopsis thaliana genome generally having at least 30%, 40%, 50%, 60%, 70%, 80%, 90% or 99% sequence identity to SBG1. Exemplary homologs of SBG1 in the Arabidopsis thaliana genome include AT3G15760 (herein referred to as “SBGl-Likel” or “SBG1L1”), AT2G35850 (herein referred to as “SBG1-LikeN or “SBG1L2”, and AT3G52360 (herein referred to as “SBG1-Like3” or “SBG1L3” The term “SBG1 protein” as used herein refers to any protein encoded by an SBG1-encoding polynucleotide. The term “SBG1L1 protein” as used herein refers to any protein encoded by an SBGILl-encoding polynucleotide. The term “SBG1L2 protein” as used herein refers to any protein encoded by an SBGlL2-encoding polynucleotide. The term “SBG1L3 protein” as used herein refers to any protein encoded by an SBGlL3-encoding polynucleotide. The term “SBG1 protein homolog” as used herein may refer to one or more of an SBG1L1 protein, an SBG1L2 protein, or an SBG1L3 protein.

[0085] The terms “ortholog” and "SBG1 ortholog” as used herein refer to polynucleotide sequences identified in species other than Arabidopsis thaliana that encode a protein generallycomprising an amino acid sequence having at least 30%, 40%, 50%, 60%, 70%, 80%, 90% or 99% sequence identity to an SBG1 protein. The term “SBG1 protein ortholog” as used herein refers to a protein comprising an amino acid sequence having at least 30%, 40%, 50%, 60%, 70%, 80%, 90% or 99% sequence identity to an SBG1 protein or an SBG1 protein homolog. Method Of Increasing Suberin Deposition In The Root Of A Plant

[0086] In one aspect, the invention provides a method of increasing suberin deposition in the root of a plant, the method comprising increasing the level or activity of a SUBER GENE 1 (SBG1) protein or a homolog or ortholog thereof in a plant.

[0087] The terms “suberin deposition” or “root suberization” are used interchangeably herein to refer to the deposition of the hydrophobic biopolymer suberin in the root endodermis of a plant.

[0088] The SBG1 protein or homolog or ortholog thereof may increase suberin deposition in the root of a plant by any means. For example, the SBG1 protein or homolog or ortholog thereof may increase suberin deposition in the root of a plant via interaction with and / or inhibition of one or more Type One Protein Phosphatases (TOPPs). The SBG1 protein or homolog or ortholog thereof may thus be a TOPP inhibitor. The TOPP may be TOPP1, TOPP2, TOPP4, TOPP5, TOPP7, and / or TOPP8. In particular, the TOPP may be TOPP2. The SBG1 protein or homolog or ortholog thereof may increase suberin deposition in the root of a plant via interaction with and / or inhibition of TOPP2. The SBG1 protein or homolog or ortholog thereof may inhibit TOPP2 phosphatase activity.

[0089] Interactions between the SBG1 protein or homolog or ortholog thereof with the one or more TOPPs may be a physical interaction or a chemical interaction. Interactions between the SGB1 protein or homolog or ortholog thereof and the one or more TOPPs may be detected by any method known in the art, for example co-immunoprecipitation, analytic gel filtration, and / or a yeast two-hybrid assay. Inhibition of the one or more TOPPs by the SBG1 protein or homolog or ortholog thereof may comprise the reduction of any catalytic activity (in particular phosphatase activity) of the one or more TOPPs. Reductions in catalytic activity may be measured using any method known in the art, for example an in vitro phosphatase assay in the case of phosphatase activity. A suitable assay is described in the Examples.

[0090] TOPPs are a family of serine / threonine phosphatases with broad functions in plants, including cell division, differentiation, salt tolerance and ABA signalling. Known TOPP inhibitors typically comprise conserved RVxF and SILK motifs which block substrate access or recruitment of substrates while controlling access to the catalytic site (Uhrig, Labandera & Moorhead, 2013, Trends in Plant Sci, 18, 505-513; He et al., 2025, Sci Adv, 11 eadq4033; Templeton et al., 2011, Biochem Jour, 435, 73-83). All 4 SBG1 genes identified in Arabidopsis (SBG1, SBG1L1, SBG1L2, and SBG1L3) harbour an RVxF motif, whilst SBG1 and SBG1L1 have also been found to contain a SILK motif. SBG1 orthologs identified in other species, for example common grape vine (Vitis vinifera), tomato (Solanum lycopersicum), corn (Zea mays), rice (Oryza sativa), and purple false brome (Brachypodium distachyon), also comprise RVxF and SILK motifs. An SBG1 protein or homolog or ortholog thereof may thus be a TOPP inhibitor and comprise an RVxF and / or SILK motif. The SBG1 protein or homolog or ortholog thereof may inhibit TOPPs by any means, for example by direct protein-protein interaction. The SBG1 or homolog or ortholog thereof may restrict TOPP catalytic activity via an RVxF motif and / or a SILK motif. The SBG1 protein or homolog or ortholog thereof may be upregulated by administration of abscisic acid (ABA) to a plant.

[0091] The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to anyof SEQ ID NOs: 1 or 8-28. The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence selected from any of SEQ ID NOs: 1 or 8-28.

[0092] The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to SEQ ID NO: 139. The SBG1 protein or homolog or ortholog thereof may comprise the amino acid sequence of SEQ ID NO: 139.

[0093] The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence having at least 80%, 85% or 90% sequence identity to any of SEQ ID NOs: 1 or 8-28, and further comprise an RVxF motif and / or a SILK motif. The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence having at least 80%, 85% or 90% sequence identity to SEQ ID NO: 139, and further comprise an RVxF motif and / or a SILK motif.

[0094] The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence having at least 80%, 85% or 90% sequence identity to any of SEQ ID NOs: 1 or 8-28, further comprise an RVxF motif and / or a SILK motif, and inhibit one or more TOPPs. The SBG1 protein or homolog or ortholog thereof may comprise an amino acid sequence having at least 80%, 85% or 90% sequence identity to SEQ ID NO: 139, further comprise an RVxF motif and / or a SILK motif, and inhibit one or more TOPPs

[0095] The polynucleotide encoding the SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 2. The polynucleotide encoding the SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence selected from any of SEQ ID NOs: 2-4.

[0096] The polynucleotide encoding the SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to SEQ ID NO: 5. The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence as defined in SEQ ID NO: 5.

[0097] The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence having least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to SEQ ID NO: 6. The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence as defined in SEQ ID NO: 6.

[0098] The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof introduced into the plant may comprise a polynucleotide sequence having least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to SEQ ID NO: 7. The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence as defined in SEQ ID NO: 7.

[0099] The terms “single nucleotide polymorphism” and “SNP” as used herein refer to genomic variations at a single nucleotide position of a polynucleotide sequence. The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise one or more single nucleotide polymorphisms (SNPs) associated with an increase in suberin deposition relative to a polynucleotide encoding the same SBG1 protein or homolog or ortholog thereof not comprising said SNP. The SNP may be in any part of the polynucleotide sequence encoding the SBG1 protein or homolog or ortholog thereof. For example, the SNP may be in the coding sequence, the 5’ untranslated region (5’ UTR), or the 3’ untranslated region (3’UTR). In Arabidopsis thaliana an SNP comprising a substitution of a “G” nucleotide 319 base pairs after the stop codon in the SBG1 coding sequence (at the position corresponding to position19,579,742 on chromosome 1 of the Arabidopsis thaliana genome) is associated with Arabidopsis thaliana accessions having an increase in suberin deposition in their roots compared to accessions comprising a “T” nucleotide at the same location. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention may therefore comprise a SNP that increases the level or activity of the SBG1 protein or homolog or ortholog thereof. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to SEQ ID NO: 3 or 4 and comprising the abovereferenced “G” allele. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may comprise a polynucleotide sequence as defined in SEQ ID NO: 3 or 4.

[0100] The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof introduced into the plant may be operably linked to a promoter. The term “promoter” as used herein refers to a region upstream of a gene where transcription is initiated. The term “operably linked” as used herein means that a functional relationship exists between the two sequences such that the promoter has the capacity to exert an influence on the expression and / or localisation and / or activity of the polynucleotide encoding the SBG1 protein. The promoter may be a heterologous promoter. The promoter may be a constitutive promoter, a tissue-specific promoter, or an inducible promoter. The term “constitutive promoter” as used herein refers to any promoter that facilitates transcription of a gene in all circumstances without requiring a stimulus. The term “inducible promoter” as used herein refers to a promoter which only facilitates transcription upon induction by a stimulus. The constitutive promoter may be any constitutive promoter known in the art. The constitutive promoter may be polyubiquitin 10 (UBQ10). The constitutive promoter may be cauliflower mosaic virus 35S (CaMV35S). The tissue-specific promoter may be any tissue-specific promoter. The inducible promoter may be any inducible promoter.

[0101] The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence having at least 80%, 85% or 90% sequence identity to any of SEQ ID NOs: 2-7, and comprise a constitutive promoter, such as UBQ10.

[0102] The polynucleotide encoding an SBG1 protein or homolog or ortholog thereof may comprise a polynucleotide sequence having at least 80%, 85% or 90% sequence identity to any of SEQ ID NOs: 2-7, wherein the polynucleotide comprises a promoter, wherein the promoter is a constitutive promoter, and be introduced into a plant selected from the group consisting of Arabidopsis thaliana, common grape vine (Vitis vinifera), tomato (Solanum ly coper sicum), com (Zea mays), rice (Oryza sativa), and purple false brome (Brachypodium distachyon).

[0103] An increase in suberin deposition in the root of the plant may be achieved by any means. For example, the increase in the level or activity of an SBG protein or a homolog or ortholog thereof in a plant may increase root suberization via interaction with TOPPs. The increase in the level or activity of an SBG1 protein or a homolog or ortholog thereof in a plant may also increase root suberization via alternative mechanisms, for example, by mediating ABA-induced root suberization.

[0104] Changes in the level or activity of an SBG1 protein or a homolog or ortholog thereof, in particular increases and decreases in the level or activity the SBG1 protein or homolog or ortholog thereof, may be measured relative to a control or reference plant not comprising an SBG1 protein or a homolog or ortholog thereof according to the present invention. Changes in the level or activity of an SBG1 protein or a homolog or ortholog thereof may be expressed as a percentage compared to the control or reference plant not comprising an SBG1 protein or a homolog or ortholog thereof according to the invention. Changes in the level or activity of an SBG1 protein or a homolog or ortholog thereof may be measured directly or indirectly.Illustrative analyses of the level or activity of SBG1 or a homolog or ortholog thereof are provided in the Examples, however any method of measuring the level or activity of a protein known in the art is suitable in accordance with the invention. The level of SBG1 protein or a homolog or ortholog thereof may be measured, for example but not limited to, immunodetection methods, fluorometric methods, biuret methods, UV absorption-based methods, and colorimetric methods. The level or activity may also be measured by quantifying the amount of SBG1, SBG1 homolog, or SBG1 ortholog DNA or RNA in a plant or plant cell. The activity of an SBG1 protein or a homolog or ortholog thereof may be measured directly or indirectly, for example but not limited to, by quantifying the level of TOPP inhibition in a plant or part thereof, analysing the pattern of suberin deposition in a plant or part thereof, and / or quantifying the amount of suberin monomers in a plant or part thereof.

[0105] Changes in suberin deposition, in particular increases and decreases in suberin deposition may be relative to a control or reference plant not comprising an SBG1 protein or a homolog or ortholog thereof according to the present invention. Illustrative embodiments of measuring suberin deposition are provided in the Examples, however any method of measuring the amount of suberin in a plant known in the art is suitable in accordance with the invention. Changes in suberin deposition may be, for example but not limited to, an increase in number of suberin monomers in the non-suberized or patchy suberin zone in the root of a plant when compared to a reference or control plant not comprising an SBG1 protein or a homolog or ortholog thereof according to the present invention. The number of suberin monomers may be measured by any method, for example but not limited to gas chromatography-mass spectrometry (GC-MS).

[0106] The control or reference plant may or may not comprise a native polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be heterologous to the plant. The term “heterologous to the plant” as used herein means that the polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention, or the SBG1 protein or homolog or ortholog thereof according to the invention is not present in the wildtype plant.

[0107] The level or activity of an SBG1 protein or a homolog or ortholog thereof may be increased by at least, for example, 5, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, 200%, 250%, 300%, 350%, 400% or greater relative to a control or reference plant.

[0108] The increase in the level or activity of an SBG1 protein or a homolog or ortholog thereof in the plant may result in an increase in the fitness of the plant. The term “fitness” as used herein refers to the metabolism, growth, viability, and / or reproduction of a plant. The increase in the fitness of the plant may be at least, for example, 5, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, 200%, 250%, 300%, 350%, 400% or greater relative to a control or reference plant. The increase in the fitness of the plant may be an increase in plant biomass, an increase in root growth, an increase in water use efficiency, an increase in stress tolerance, and / or an increase in the carbon sequestration capacity of the plant. The increase in plant biomass, root growth, water use efficiency, stress tolerance, and / or carbon sequestration capacity of the plant may be at least, for example, 5, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, 200%, 250%, 300%, 350%, 400% or greater relative to a control or reference plant. Methods of measuring plant biomass, root growth, water use efficiency, stress tolerance, and carbon sequestration capacity are known in the art. As used herein the terms "biomass" and "plant biomass" refers to the amount (e.g., measured in grams of air-dry tissue) of a tissue produced from the plant. An increase in plant biomass can be in the whole plant or in parts thereof such as aboveground (e.g. harvestable) parts, vegetative biomass, roots and / or seeds. The term “water use efficiency” as used herein means the amount of carbon assimilatedas biomass or grain produced per unit of water used. The term "stress" as used herein refers to any adverse effect on metabolism, growth, viability and / or reproduction of a plant. The term “stress tolerance” as used herein refers to mitigate some or all of the negative effects on fitness caused by abiotic and / or biotic stresses. The plant may demonstrate an increase in tolerance to one or more biotic stresses including, but not limited to, a pathogen-induced stress, weed-induced stress, and / or pest-induced stress. The plant may demonstrate an increase in tolerance to one or more abiotic stresses including, but not limited to, a drought stress, salt stress, stress induced by exposure to toxic elements, stress induced by exposure to heavy metals, oxidative stress, waterlogging stress, and / or nutrient deficiency stress. The term “nutrient deficiency stress” as used herein refers to a condition wherein the soil surrounding a plant contains a suboptimal amount of minerals and / or other nutrients required for survival, growth and / or reproduction. The micronutrient deficiency stress may include a deficiency in one or more of zinc (Zn), boron (B), copper (Cu) and molybdenum (Mo). The plant may increase accumulation of one or more micronutrients such as Zn, B, Cu, Mo. The plant may demonstrate an increase in tolerance to one or more biotic stresses and / or one or more abiotic stresses described herein. The term “carbon sequestration capacity” as used herein refers to the amount of carbon dioxide absorbed by a plant from the atmosphere and / or store carbon in the soil.

[0109] The level or activity of an SBG1 protein or a homolog or ortholog thereof may be increased by any means. The method may comprise introducing into the plant a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof introduced into the plant may be a DNA or an RNA sequence. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof introduced into the plant may be comprised in a vector. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into a whole plant or a part thereof by any means. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into one or more plant cells. Various methods of direct transfer of a polynucleotide into a plant or plant cells are known in the art. A polynucleotide may be introduced by any suitable means, for example by electroporation, microinjection or microparticle bombardment.

[0110] One or more polynucleotides encoding an SBG1 protein or a homolog or ortholog thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 and 8-28 or variants thereof as described above may be introduced into the plant. Two or more polynucleotides encoding an SBG1 protein or a homolog or ortholog thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 and 8-28 or variants thereof may be introduced into the plant. Three or more polynucleotides encoding an SBG1 protein or a homolog or ortholog thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 and 8-28 or variants thereof may be introduced into the plant. The one, two, or three or more polynucleotides encoding an SBG1 protein or a homolog or ortholog thereof introduced into the plant may comprise a polynucleotide encoding an SBG1 protein comprising the amino acid sequence of SEQ ID NO: 139 or a variant thereof. The term “variant” as used herein refers to a polynucleotide sequence comprising at least 60%, 70%, 80%, 90% or 99% sequence identity to the referenced sequence.

[0111] The term "introducing" as used herein is intended to mean presenting to the plant the polynucleotide in such a manner that the sequence gains access to the interior of a cell of the plant. The methods of the disclosure do not depend on a particular method for introducing a sequence into a plant, only that the polynucleotide or polypeptides gains access to the interior of at least one cell of the plant. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into a plant or plant cell via direct gene transfer,microinjection, transformation, vector-based methods and / or virus-mediated methods. The polynucleotide or vector encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into a plant or plant cell may be introduced into a plant (including plant cells, such as callus, cultured cells, and protoplasts) by any method known in the art for introducing DNA into plant cells. The method of transforming plants may be Agrobacterium tumefaciens- mediated transformation or microparticle bombardment. Agrobacterium tumefaciens-mediated transformation may occur via floral dipping. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into plants by contacting plants with a virus or viral nucleic acids. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be comprised in a vector that is introduced into the plant using, for example but not limited, gateway cloning (e.g. single-site or multisite gateway cloning), comprising the creation of entry clones comprising a polynucleotide of interest, wherein the entry clone is subsequently recombined with a destination vector to generate an expression clone comprising the polynucleotide of interest. The transformation may be a stable transformation or a transient transformation. The term "stable transformation" as used herein a transformation in which the polynucleotide construct introduced into a plant integrates into the genome of the plant and is capable of being inherited by the progeny thereof. Generally, such methods involve incorporating a nucleotide construct of the disclosure within a viral DNA or RNA molecule. The term "transient transformation" as used herein means that a polynucleotide is introduced into the plant and does not integrate into the genome of the plant or a polypeptide is introduced into a plant. Whilst stable transformation is preferred, transient transformation of root cells, meristematic cells or the whole plant is also described herein. Transformation protocols as well as protocols for introducing polynucleotide sequences into plants may vary depending on the type of plant or plant cell, i.e., monocot or dicot, that is targeted for transformation. The plant may thus be transformed with a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof.

[0112] Following transformation, plant propagation may be performed. Propagation may occur by any method known in the art, for example but not limited by seed or by micropropagation. Micropropagation may be a preferred means of regeneration to ensure that the regenerated plant has the same genotype and characteristics of the transformed parent plant.

[0113] The plant may be any plant described herein. The plant may preferably be selected from the group consisting of Arabidopsis thaliana, Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza sativa, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza sativa, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda. The amino acid sequences for the SBG1 protein and orthologs thereof identified in these preferred species are provided in SEQ ID NOs: 1 and 11-28, respectively.

[0114] Polynucleotide Encoding An Sbgl Protein

[0115] In another aspect, the invention provides a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof.

[0116] The polynucleotide encoding an SBG1 protein may be DNA or RNA. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be comprised in a vector. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may comprise a promoter. The promoter may be any promoter described previously. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may comprised in a cell. Thepolynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may isolated from a cell.

[0117] The SBG protein or homolog or ortholog thereof encoded by the polynucleotide may be any SBG1 protein or homolog or ortholog thereof in accordance with the SBG1 proteins, SBG1 protein homologs, and SBG1 protein orthologs of the invention described previously. For example, the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide may comprise an amino acid sequence having at least 60, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99%% sequence identity to any of SEQ ID NOs: 1 or 8-28. The SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide may comprise an amino acid sequence having at least 60, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99%% sequence identity to SEQ ID NO: 139.

[0118] The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be any polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof in accordance with the polynucleotides of the invention described previously. For example, the polynucleotide may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 2-7. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may comprise any of SEQ ID NOs: 2-7. Vector

[0119] The invention further provides a vector comprising a polynucleotide according to the invention.

[0120] The term “vector” as used herein typically refers to a DNA molecule such as a plasmid, cosmid or bacterial phage for introducing a polynucleotide in accordance with the invention.

[0121] The vector may be an expression vector designed to facilitate expression of a polynucleotide in accordance with the invention into a plant or plant cell. Vectors may include a marker or reporter gene that is suitable for use in the identification and selection of cells transformed with the vector. Marker genes typically include genes that provide tetracycline resistance, hygromycin resistance or ampicillin resistance. Genes encoding fluorescent proteins may also be used to identify and select cells or plants transformed with the vector. Exemplary fluorescent proteins suitable for use in accordance with the invention include genes include genes encoding fluorescent proteins, such as mCherry, mScarlet, and mVenus.

[0122] Cell

[0123] In another aspect, the invention provides a cell comprising a polynucleotide or a vector according to the invention.

[0124] The cell may be any type of cell. The cell is typically a plant cell. The plant cell may be derived from or isolated from plant cell tissue or a plant cell culture. The plant cell may be derived from the endodermis, exodermis, or periderm in the root of a plant.

[0125] The plant cell may be a root cell. The root cell may be an endodermal root cell, an epidermal root cell, or a cortical root cell. The root cell may preferably be a root endodermal cell.

[0126] The cell may be comprised in a whole plant.

[0127] Plants And Parts ThereofIn another aspect, the invention provides a plant or part thereof comprising a polynucleotide, a vector, or a cell according to the invention.

[0128] The term “plant” as used herein relates to whole plants. The term “plant part” as used herein includes plant organs (e.g., leaves, stems, roots, etc.), plant cells, plant protoplasts, plant cell tissue cultures from which plants can be regenerated, plant calli, plant clumps and plant cells that are intact in plants or parts of plants such as embryos, pollen, ovules, seeds, seedlings, leaves, flowers, branches, fruit, kernels, ears, cobs, husks, stalks, roots, root tips, anthers and the like.

[0129] The plant may be generated or obtained by any means known in the art. The plant may or may not be obtained by means of an essentially biological process.

[0130] Polynucleotides, vectors, and cells according to the invention may be introduced into any plant species, including, but not limited to, any monocotyledonous (monocots) and dicotyledonous (dicots) plants. Examples of suitable plant species for all aspects of the invention include Arabidopsis thaliana, common grape vine (Vitis vinifera), tomato (Solarium lycopersicum), corn (Zea mays), rice (Oryza saliva), purple false brome (Brachypodium distachyon), melon (Cucmis melo), black cottonwood (Populus trichocarpa) cucumber (Cucumis sativus), wild carrot (Daucus carota), beet (Beta vulgaris), chickpea (Cicer arientinum), Lotus japonicus, Medicago truncatula, Amborella trichopoda, Taxus chinensis, Brassica sp. (e.g., B. napus, B. rapa, B. juncea), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetum glaucum), proso millet (Panicum miliaceum), foxtail millet (Setaria italica), finger millet (Eleusine coracana)), sunflower (Helianthus annuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanum tuberosum), peanuts (Arachis hypogaea), cotton (Gossypium barbadense, Gossypium hirsutum), sweet potato (Ipomoea batatus), cassava (Manihot esculenta), coffee (Coffea spp.), coconut (Cocos nucifera), pineapple (Ananas comosus), citrus trees (Citrus spp.), cocoa (Theobroma cacao), tea (Camellia sinensis), banana (Musa spp.), avocado (Per sea americana), fig (Ficus casica), guava (Psidium guajava), mango (Mangifera indica), olive (Olea europaea), papaya (Carica papaya), cashew (Anacardium occidentale), macadamia (Macadamia integrifolia), almond (Prunus amygdalus), sugar beets (Beta vulgaris), sugarcane (Saccharum spp.), Setaria italica, oats, barley (Hordeum vulgare), vegetables, ornamentals and conifers. Preferred species to which the invention may be applied include Arabidopsis thaliana, Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza saliva, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza saliva, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda.

[0131] Uses

[0132] In another aspect, the invention provides a use of a polynucleotide according to the invention for increasing suberin deposition in the root of a plant. The increase in suberin deposition and polynucleotide may be as described above in the context of the methods of the invention.

[0133] Increasing the suberin deposition in the root of the plant may increase the fitness of the plant as described above. The increase in the fitness of the plant may be an increase in plant biomass, an increase in root growth, an increase in water use efficiency, an increase in stress tolerance, and / or an increase in the carbon sequestration capacity of the plant. The plant may demonstrate an increase in tolerance to one or more biotic stresses including, but not limited to,a pathogen-induced stress, weed-induced stress, and / or pest-induced stress. The plant may demonstrate an increase in tolerance to one or more abiotic stresses including, but not limited to, a drought stress, salt stress, stress induced by exposure to toxic elements, stress induced by exposure to heavy metals, oxidative stress, waterlogging stress, and / or nutrient deficiency stress. The micronutrient deficiency stress may include a deficiency in one or more of zinc (Zn), boron (B), copper (Cu) and molybdenum (Mo). The plant may demonstrate an increase in tolerance to one or more biotic stresses and / or one or more abiotic stresses described herein. Method Of Producing Plants Having Increased Root Suberin Deposition

[0134] In another aspect, the invention provides a method of producing a plant having increased root suberin deposition.

[0135] The method of “producing a plant” may comprise any means known in the art for producing, generating, and / or regenerating plants. For example, a plant may be produced, generated, or regenerated from seed or by micropropagation. The plant may or may not be produced by means of an essentially biological process.

[0136] The method of producing a plant having increased root suberin deposition may include introducing into the plant a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof, as described above. The plant may or may not comprise a native polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be heterologous to the plant.

[0137] The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into the plant by any means. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into the plant by direct gene transfer, microinjection, transformation and / or virus-mediated methods. The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof may be introduced into the plant by Agrobacterium tumefaciens-mediated transformation.

[0138] The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof introduced into the plant may comprise any promoter described herein.

[0139] The SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide introduced into the plant may be any SBG1 protein or homolog or ortholog thereof in accordance with the SBG1 proteins, SBG1 protein homologs or SBG1 protein orthologs of the invention described previously. For example, the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide introduced into the plant may comprise an amino acid sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 1 or 8-28. The SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide introduced into the plant may comprise an amino acid sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to an amino acid sequence selected from any of SEQ ID NOs: 1 or 8-28, and the SBG1 protein or homolog or ortholog thereof may comprise an RVxF motif and / or an SILK motif.

[0140] The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof introduced into the plant may be any polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof in accordance with the polynucleotides of the invention described previously. For example, a polynucleotide encoding an SBG1 protein or a homolog thereof introduced into the plant may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 2-7. The polynucleotideencoding an SBG1 protein or a homolog thereof introduced into the plant may comprise any of SEQ ID NOs: 2-7.

[0141] The polynucleotide encoding an SBG1 protein or a homolog thereof introduced into the plant may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 2-7, and be introduced into a plant selected from the group consisting of Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza sativa, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza sativa, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda.

[0142] One or more polynucleotides encoding an SBG1 protein or a homolog thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 and 8-28 or variants thereof may be introduced into the plant.

[0143] Method Of Introgressing A Polynucleotide Encoding An SBG1 Protein Into Plants

[0144] In another aspect, the invention provides a method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention into a plant.

[0145] The terms “introgression” and “introgressing” as used herein refer to the incorporation of a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof from a first plant into a second distinct plant by any means. The method of introgression may comprise hybridization followed by repeated backcrossing of the first and second plant. The first and second plant may represent distinct species, cultivars, or accessions.

[0146] Methods of introgressing polynucleotides into plants are known in the art. The method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof into a plant may comprise crossing and selection. The method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof into a plant may comprise crossing a first plant comprising a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof with a second plant lacking a native polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof so as to produce a population of offspring comprising said polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof.

[0147] The method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof into a plant may comprise selecting offspring comprising the polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof. The method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof into a plant may comprise (i) crossing a first plant comprising a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof with a second plant lacking a native polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof so as to produce a population of offspring comprising said polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof; and (ii) selecting offspring comprising the polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof.

[0148] Methods of selection are known in the art. Selection may be based on the detection of a marker gene, for example but not limited to, a fluorescence gene or an antibiotic resistance gene.

[0149] The polynucleotide introgressed into the offspring may comprise any promoter described herein.The SBG protein or homolog or ortholog thereof encoded by the polynucleotide introgressed into the offspring may be any SBG1 protein or homolog or ortholog thereof in accordance with the SBG1 proteins, SBG1 protein homologs, and SBG1 protein orthologs of the invention described previously. For example, the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide introgressed into the offspring may comprise an amino acid sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 1 or 8-28. The SBG protein or homolog or ortholog thereof introgressed into the offspring may comprise an amino acid sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to an amino acid sequence selected from any of SEQ ID NOs: 1 or 8-28, and further comprise an RVxF motif and / or an SILK motif.

[0150] The polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof introgressed into the offspring may be any polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof in accordance with the polynucleotides of the invention described previously. For example, a polynucleotide encoding an SBG1 protein or a homolog thereof introgressed into the offspring may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 2-7. The polynucleotide encoding an SBG1 protein or homolog thereof may comprise a polynucleotide sequence selected from any of SEQ ID NOs: 2-7.

[0151] The polynucleotide encoding an SBG1 protein or a homolog thereof introgressed into the offspring may comprise a polynucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% sequence identity to any of SEQ ID NOs: 2-7, and be introgressed into a plant selected from the group consisting of Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza sativa, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza sativa, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda.

[0152] One or more polynucleotides encoding an SBG1 protein or a homolog or ortholog thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 and 8-28 or variants thereof may be introgressed into the offspring.

[0153] Plants And Plant Cells Obtainable By The Methods Of The Invention

[0154] The invention further provides plants and plant cells obtainable by any of the methods according to the invention described herein. Thus, the plants or plant cells may be obtainable by introducing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof according to the invention into a plant or plant cell or by increasing suberin deposition in a plant or plant cell by increasing the level or activity of an SBG1 protein or a homolog or ortholog thereof. The plant or plant cells obtained in accordance with the invention may be of any species described herein, for example Arabidopsis thaliana, Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza sativa, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza sativa, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda.EXAMPLES

[0155] Reference is now made to the following examples, which together with the above descriptions illustrate some embodiments of the invention in a non-limiting fashion.

[0156] Example 1 - Analysis of natural suberin variation in Arabidopsis thaliana accessions

[0157] To explore the variation of endodermal suberin deposition in A. thaliana, the inventors analyzed the suberin pattern in 284 genetically diverse natural accessions, which represent a subset of the 1001 Genomes Project17, including 185 of the 195 Salk accessions, 80 Max-Planck Institute accessions, and the 19 founder accessions used to generate the MAGIC (Multiparent Advanced Generation Inter-Cross) population18.

[0158] Seeds were surface sterilized using chlorine gas and sown on square plates. Seedlings were grown on half-strength MS (Murashige and Skoog) medium (pH 5.7) containing 0.8 % agar without sucrose. MES (0.5 g / L) was added and pH adjusted to 5.7 with KOH. seeds were stratified for 7 days at 4°°C to minimize germination variability. Seedlings were grown vertically in growth cabinets set to 22°C under continuous light (-100 pE) and 40% relative humidity. For propagation, plants were grown under long-day conditions (16 h light / 8 h dark) at 20 ± 2°C, with a light intensity of 150-180 pE and 60% relative humidity.

[0159] To visualise suberin deposition, 4-day-old whole A. thaliana seedlings were immersed in Fluorol Yellow 088 (0.01% w / v, lactic acid; Chem Cruz, Cat# sc-215052) and incubated at 70°°C for 30 minutes in the dark.

[0160] After staining, seedlings were washed twice with water and counterstained with aniline blue (0.5% w / v; Sigma-Aldrich, Cat# 415049) for 30 minutes at room temperature in the dark, followed by two additional water washes.

[0161] Seedlings were then mounted on slides in 50% glycerol and scanned using a ZEISS Axio Zoom. VI 6 stereomicroscope equipped with a GFP filter (excitation: 450-490 nm, emission: 500-550 nm). Full root imaging at high resolution was achieved using a tile-scanning approach. The region of interest (RO I) was first defined during a low-resolution scan (7x magnification). Focus points were manually selected along the root to ensure consistent focus, and high-resolution images (63x magnification) were captured as overlapping tiles (10% overlap) that were subsequently stitched together.

[0162] The pattern of suberin deposition in various accessions was analysed by measuring the lengths of three distinct suberin zones along the root (non-suberized, patchy, and fully suberized) using Fiji25software.

[0163] A wide range of suberin patterns was observed, particularly in the fully suberized zone (Figure 1).

[0164] The geographical distribution of all accessions, particularly those with extreme suberin deposition levels was also mapped, which revealed a trend of strong accessions predominantly located in southern Europe, the Mediterranean region, and continental Eurasia. To further investigate potential effect of environmental influences on root suberization, the inventors analyzed correlations between suberin deposition and 473 climate variables. Climatic data for the Arabidopsis accessions analyzed in were retrieved from AraCLIM (http s : / / github . com / CLIMtool s / AraCLIM)26. Relevant climate variables were selected and extracted for the geographic origin of the characterized accessions. Analysis of correlations between suberin quantification and environmental variables were performed using nonparametric Spearman correlation analysis in GraphPad Prism 10 (https: / / www.graphpad.com / ).Several strong positive correlations were identified, including those with temperature during the warmest month, summer solar radiation, precipitation seasonality, and the global terrestrial drought index. Collectively, these findings indicate that the observed suberin variations reflect adaptive responses to local environmental factors, particularly temperature, light and water availability.

[0165] Example 2 - Identification of SBG1 as the genetic basis for variation in suberin deposition

[0166] To uncover the genetic basis of natural variation in endodermal suberin deposition, the inventors performed a Genome Wide Association Study (GWAS) for the fully suberized zone quantified in 265 accessions using the GWA-Portal platform and Imputed Full sequence Dataset corresponding of a combination of the 250K SNP dataset and the 1001 genomes dataset using imputation (TAIR9)28. An accelerated mixed model (AMM) was applied for the GWAS and a significance threshold of 10% was used after Bonferroni -Hochberg correction for multiple tests (see Figures la and 4a-c)6. The GWAS approach identified two significant loci on chromosomes 1 and 4 (Figure 2a). The lead SNP on chromosome 1 (19,579,742 bp) was located 319 bp downstream oi AT1G52565, a previously uncharacterized gene encoding a 129 amino acid protein, later designated SUBER GENE1 (SBG1) (Figure 2b). On Chromosome 4, two SNPs (2,769,796 and 2,769,807 bp) mapped between AT4G05475 and AT4G05490 encoding putative F-BOX proteins but given their greater distance from the SNPs (1839 bp and 1236 bp, respectively) (Figure 4d), the inventors focused on the Chromosome 1 locus. Accessions carrying the G allele at position 19,579,742 on chromosome 1 exhibited significantly higher suberin levels than those with the T allele (Figure 4e).

[0167] To validate the role of SBGf the inventors quantified suberin deposition in available T-DNA insertion lines in Col-0 for genes within ±15 Kb of the lead SNP (Figure 2c). Seedlings were grown in accordance with the method described in Example 1, with the exceptions that 5-day old seedlings were used, and stratification was performed for 2 to 3 days at 4°C. The T-DNA insertion lines trialled: sbgl-1 (SALK_029983C), s6-2 (SALK_114017C)19, allg525](’ (GK-090F10), atlg52550 (SAZL 681 G01), plda2 (GK-212E06), rbl5 (SALK 079189C), atlg52590 (SAIL 894 H03.C), and atlg52600 (SALK 062346C) were obtained from the Nottingham Arabidopsis Stock Centre, and genotyping primers are provided in Table 1. Only the sbgl-1 mutant showed significantly reduced suberin compared to Col-0 accessions (Figures 2c, d, and 4f). This phenotype was independently confirmed in CRISPR-Cas9-induced sbgl mutants in the strong accessions Leo-1 and Tsu-0, further supporting the role of SBG1 in suberization (Figures 2e, f, and 4g-i).Table 1

[0168] Genotyping Gene ID T-DNA NASC Left / Sequence SEQ primer No. Right ID primer NO: frs6-2 AT1G52520 SALK 114017C N686674 Left ATTCTCGAGAGCTGTGTCTCG 29

[0169] Right GCTGCCATCTCTCAAGTGTTC 30 atlg52540 AT1G52540 GK-090F10 N408614 Left TTCTTGCTTTGATCCGTTTTG 31

[0170] Right CAGCAATATTCATCCGCCTAG 32 atlg52550 AT1G52550 SAIL 681 G01 N829878 Left TTTGGCATTTTGACTTAAATGC 33

[0171] Right TTCGTCTTTCCCTTCTTACCC 34 sbgl-1 AT1G52565 SALK 029983C N659778 Left TCCACTTGATTTTTGAGCCTG 35

[0172] Right GGAGCACTGAATTCGATGATC 36 plda2 AT1G52570 GK-212E06 N420310 Left GAGAGGATCCGCGAGATTATC 37

[0173] Right TTGTGTCGGGAAAGAATTCAC 38 rbl5 AT1G52580 SALK 079189C N675863 Left CGTTCTTCTTGCAGTTTGCTC 39

[0174] Right TTGTAGTGCACCGCACTTATG 40 atlg52590 AT1G52590 SAIL 894 H03.C N868552 Left TCTTCCTGACCGCAATAACAG 41

[0175] Right CTTTGTCTCAAAAGCGTTTGC 42 atlg52600 AT1G52600 SALK 062346C N686096 Left TAACGGCCAATGAGAAGACAC 43

[0176] Right TGATTCTTGGGCGTTTATCAC 44 toppl AT2G29400 SALK 057537 N557537 Left TCAACGTTAAACTTTTGCAGG 45

[0177] Right GCTAATTCAAACTTTTTGGCG 46 topp2 AT5G59160 GK-187C10 N417890 Left GGAGATTACGTAGACAGGGGC 47

[0178] Right TCGCCTTTTTCCTCTTCTTTC 48 topp3 AT1G64040 WiscDsLoxHs037_l 1C N865039 Left CATGTCTTACCAACAGTTGATCC 49

[0179] Right AGGAGCCTCGAGTTCAAGAAG 50 topp4 AT2G39840 GK-335F03 N432127 Left ATCAGTGCAAGAGAATCCTTTCAT 51

[0180] Right CATTTTGCATCCTTCGTGTTC 52 topp6 AT5G43380 SALK 093747C N658819 Left GTTAGAGATTCCGAGCTTGCC 53

[0181] Right CTTGGAGATTATGTCGATCGC 54 topp7 AT4G11240 SALK 023073C N678236 Left TGGAATTGATGGTGAAAGATTG 55

[0182] Right TATTGACGTTCCTGATCAGGG 56 topp8 AT5G27840 SALK 137888 N637888 Left GGCCTTTGAATCTCTCGAATC 57

[0183] Right AAAATGAAATGCCAAGTGGAC 58 topp9 AT3G05580 SALK 045433C N656443 Left AAGAGCCAAACCATGGAAGTC 59

[0184] Right GGGAGATTCAAAGGCCTACAG 60 sbgl-2, AT1G52565 CRISPR - Left CACACACATATTCATCATTCATCAG 61 sbgl-3,

[0185] sbgl-4 Right GGAGCACTGAATTCGATGATC 62 sbglll AT3G15760 CRISPR - Left TTCACAGCCAATCATCGATCAC 63

[0186] Right 64 AGTCAATAAGAATATTGAACTCTGTG

[0187] sbgll2 AT2G35850 CRISPR - Left 65

[0188] AACTGTTTCATAAGTTGGAAAAGAAG

[0189] Right AAAAAGACATGGAATGGGGTATGT 66 sbgll.3 AT3G52360 CRISPR - Left TTCCAGTTGATTACCGGAGAATTT 67

[0190] TGAAAAGTTTAGCCCAGATTCAGA 68

[0191]

[0192] RightTo further investigate the role of SBG1 in suberin deposition, the inventors functionally characterized the gene in Col-0.

[0193] CRISPR-Cas9 constructs targeting SBG1 were designed using Benchling (https: / / www.benchling.com / ) (see Table 2). The CRISPR-induced mutations all caused a loss of function as an early frameshift meant than no functional SBG1, SBG1L1, SBG1L2 and / or SBG1L3 protein was produced. In the following examples, “sbgl”, “sbglll”, “sbgll2”, and “sbgll3”, when written without capitalisation, are used to indicate that a mutant comprises a CRISPR-induced loss of function mutation for one or more of the referenced SBG1 genes.

[0194] Table 2

[0195] Gene Primer direction Primer sequence SEQ ID NO: SBG1 Forward ATTGGAGAATGTGAAAGAGACGAA 69

[0196] Reverse AAACTTCGTCTCTTTCACATTCTC 70

[0197] SBG1L1 Forward ATTGGTAACGGGGAAGAGTACCGG 71

[0198] Reverse AAACCCGGTACTCTTCCCCGTTAC 72

[0199] SBG1L2 Forward GTCACTTCGCCGTCTCTGGAAGCG 73

[0200] Reverse AAACCGCTTCCAGAGACGGCGAAG 74

[0201] SBG1L3 Forward ATTGGAGTTCATTAGGTTTCATGG 75

[0202]

[0203] Reverse AAACCCATGAAACCTAATGAACTC 76 Oligonucleotides for guide RNAs were annealed, digested by BbsI, and ligated into the pEn-Chimera vector20. The resulting entry constructs were recombined by Gateway (Thermo Fisher Scientific) into a destination vector containing the UBQ10::SpCas9 and a FAST Red selection marker21. Entry clones for expression constructs were generated using Gibson assembly following PCR amplification. PCR products were cloned into a BamHI-digested pUC57-L4_EcoRV-XbaI-BamHI _R1 or into a Notl-digested pDONR.221- / . / Spel-BgHI-Notl-Sphl-EcoRI L2. Expression clones were generated using the Multisite Gateway Technology (Life Technologies, Carlsbad, CA, USA) by recombination of entry clones into the destination vectors pFR7m34GW (FAST Red) or pFG7m34GW (FAST Green)22. Primers used for cloning are listed in Table 3.

[0204] Table 3

[0205] Cloning primer Primer Sequence SEQ direction ID NO: pEN-L4-pSBGl- Forward AAGTTGGATATCAGATCTTCTAGAGTTCT 77 R1 TGAGGAATCCTGATGAATAAAC

[0206] Reverse TTCAACTTTTTTGTACAAACTTGCGAGTGT 78

[0207] TTGAAAGATAAAAGATTCAGAA

[0208] pEN-L4- Forward GTTGGATATCAGATCTTCTAGAGTTGAAA 79 pTOPP2-Rl GTTTAAACTTTCGTTTTCTATTG

[0209] Reverse CTTTTTTGTACAAACTTGCGTCGAAAGAA 80

[0210] GACCCACCTCC

[0211] Forward GCAGGCTTACTAGTAAGATCTGCATGACT 81

[0212]

[0213] TGTATACTAAGCTGTTCTCloning primer Primer Sequence SEQ direction ID NO: pEN-Ll- Reverse GGGTTGAATTCATAAAGGCATGCATCTAC 82 gSBGl J’UTR a TTTGTTATTTAAAAACCGTTTC

[0214] cc-L2

[0215] pEN-Ll- Forward GCAGGCTTACTAGTAAGATCTGCATGACT 83 gSBGl nostop- TGTATACTAAGCTGTTCT

[0216] L2 Reverse GGGTTGAATTCATAAAGGCATGCATAGGA 84

[0217] GCACTGAATTCGATGA

[0218] pEN-Ll- Forward GCAGGCTTACTAGTAAGATCTGCATGGAA 85 CYP86A 1 cds-L2 GCTCTAAACTCTATCTTAA

[0219] Reverse GGGTTGAATTCATAAAGGCATGCTGCAAG 86

[0220] CACCTCACCACGA

[0221] pEN-Ll- Forward GCAGGCTTACTAGTAAGATCTGCATGGTT 87 GPA T5 cds-L2 ATGGAGCAAGCTGGAA

[0222] Reverse GGGTTGAATTCATAAAGGCATGCATGGAG 88

[0223] ACAAGGCTCGAAAGT

[0224] pDONR221-Ll- Forward GGGGACAAGTTTGTACAAAAAAGCAGGC 89 SBG1 88 cds-L2 TTACGCCAATTTTCTGGAAATCAGAC

[0225] Reverse GGGGACCACTTTGTACAAGAAAGCTGGGT 90

[0226] TTCAATAGGAGCACTGAATTCGAT

[0227] pDONR221-Ll- Forward GGGGACAAGTTTGTACAAAAAAGCAGGC 91 TOPP1 cds-L2 TTAGCGGAGAAGCCGGCGCA

[0228] Reverse GGGGACCACTTTGTACAAGAAAGCTGGGT 92

[0229] TTCACAGAAAAGGCGACTTCTTTT

[0230] pDONR221-Ll- Forward GGGGACAAGTTTGTACAAAAAAGCAGGC 93 TOPP2 cds-L2 TTAGCGCAACAAGGGCAGGGA

[0231] Reverse GGGGACCACTTTGTACAAGAAAGCTGGGT 94

[0232]

[0233] TTCATAAGAACCGGGGCTTTCG

[0234] Final constructs were introduced into Arabidopsis using Agrobacterium tumefaciens strain GV3101 and the floral dip method23. For each construct, at least 14 T1 seeds were selected based on fluorescence (FAST Red or FAST Green)24. Segregation ratios, gene expression levels, and phenotypes were analyzed across 14 independent T2 lines. All experiments were conducted on T3 homozygous lines with mono-insertional events unless otherwise noted.

[0235] Seedlings were grown in accordance with the method described in Example 1, with the exceptions that 5-day old seedlings were used, and stratification was performed for 2 to 3 days at 4°C. The reduced suberin phenotype observed in sbgl-1 mutants (Figures 2c and d) was confirmed in sbgl-2 mutants generated by CRISPR-Cas9 (Figures 3a, b, and 7a). Introducing either SBG1 or SBGl-mVenus under of their native promoter fully restored root suberization in sbgl-1 mutants (Figures 3a and b). Furthermore, constitutive expression of SBGl-mVenus under the UBQ10 promoter significantly enhanced suberization near the root tip (Figure 3c and d), mirroring the effect observed when G alleles are expressed in weak accessions carrying the T allele at position 19,579,742 on chromosome 1 (Figures 2h-j).

[0236] This enhanced suberization was corroborated by chemical analysis of whole root suberin content. Suberin monomer analysis in roots was conducted by gas chromatography-mass spectrometry (GC-MS) following a previously described protocol27. Roots from 5 -day-oldseedlings (200-300 per replicate) were harvested and incubated in isopropanol containing 0.01% butylated hydroxytoluene (BHT) at 85°C for 10 minutes. Delipidization was performed twice (16 hours and 8 hours) using extractions with chloroform-methanol (2: 1), chloroform-methanol (1:1), and methanol with 0.01% BHT, with samples continuously agitated. The delipidized samples were vacuum-dried for 3 days before depolymerization via base catalysis. For depolymerization, dried plant material was subjected to trans-esterified in a reaction medium (20 mL) composed of 3 mL methyl acetate, 5 mL of 25% sodium methoxide in dry methanol, and 12 mL dry methanol. Methyl heptadecanoate (5 mg) and w-pentadecalactone (10 mg) were added as internal standards per sample. The samples were incubated at 60°C for 2 hours, followed by the addition of 3.5 mL di chloromethane, 0.7 mL glacial acetic acid, and 1 mL 0.9% NaCl in 100 mM Tris buffer (pH 8.0). Samples were vortexed for 20 seconds and centrifuged at 1500 x g for 2 minutes. The organic phase was collected, washed with 2 mL 0.9% NaCl, dried over sodium sulfate, and concentrated under a nitrogen stream. The suberin monomers were derivatized with N,O-bis(trimethylsilyl)trifluoroacetamide (BFTSA) in pyridine (1:1, v / v) at 70°C for 1 hour before GC-MS analysis. Samples were injected in hexane onto an HP-5MS column (J&W Scientific) using an Agilent 6890N GC Network systems coupled to a mass spectrometer and flame ionization detector. The oven temperature was programmed as follows: 50°C for 2 minutes, an increase of 20°C / min to 160°C, 2 °C / min to 250°C, and 10°C / min to 310°C, held for 15 minutes. The amounts of unsubstituted C16 and Cl 8 fatty acids were excluded from the analysis due to their widespread occurrence in plants and the environment. The analysis revealed a significant increase in suberin monomers, with a 34% increase in total aliphatic content in lines constitutively expressing SBG1 (Figures 3e and f).The inventors also assessed how allelic variation in SBG1 affects root suberization. Sequence analysis of T and G alleles revealed multiple additional SNPs in the 3’ region (Figure 2g). To functionally assess allelic-specific effects, the inventors cloned the genomic sequences of SBG1, including 1,500 bp of the 3’ region, from accessions carrying either the G allele (Shigu-1, Sf-2 and Tsu-0) or the T allele (Lm-2, Nc-1 and Litva). These constructs were expressed under the constitutive and ubiquitous UBQ10 promoter in accessions carrying the T allele using the CRISPR-Cas9 system described herein, with the entry clones - Ll-SBGl_acc-L2 (the genomic SBG1 sequence including 1500 bp of 3’ region from specified accession). Seedlings were grown in accordance with the method described previously, with the exceptions that 5 -day old seedlings were used, and stratification was performed for 2 to 3 days at 4°C. Constitutive expression of the G alleles in weak accessions (Lm-2, Nc-1 and Litva) significantly enhanced suberization near the root tip (Figures 2h-j). These findings establish SBG1 as a key positive regulator of suberization across natural accessions, demonstrating that allelic variations in SBG1 modulate suberin deposition in the root endodermis.

[0237] Example 3 - SBG1 contributes to ABA-induced root suberization

[0238] A defining feature of genes involved in suberin formation is their specific expression in the root endodermis and their induction by ABA2,3’4’5’7’8. Whole-root expression analysis using quantitative reverse transcriptase PCR (qRT-PCR) revealed that SBG1 was upregulated after ABA treatment (Figure 7b), reaching levels comparable to CYP86A1 (also known as HORST, HYDROXYLASE OF ROOT SUBERIZED TISSUE).

[0239] Gene expression analyses were performed using roots from 7-day-old seedlings, with approximately 60 roots pooled per biological replicate (3 biological replicates per genotype and conditions). After harvesting, roots were immediately frozen in liquid nitrogen andsubsequently ground to a fine powder using a tissue lyser. Total RNA was extracted using the TRIzol reagent (Ambion) and further purified with the RNeasy MinElute Cleanup Kit (Qiagen). Reverse transcription was performed with the Maxima First Strand cDNA Synthesis Kit (Thermo Scientific). Quantitative real-time PCR (qRT-PCR) was conducted on an Applied Biosystems QuantStudio5 thermocycler using SYBR Green master mix (Applied Biosystems). The expression levels were normalized to the housekeeping gene ClathrinAP4M (AT4G24550 ., and relative expression was calculated using the 2'AACtmethod29. Primers used for qRT-PCR are detailed in Table 4.

[0240] Table 4

[0241] qPCR primer Primer Sequence SEQ ID direction NO:

[0242] SBG1 Forward TTCTGGAAATCAGACATCAGATC 95

[0243] A

[0244] Reverse CGTCTCTTTCACATTCTCTGCA 96 GPAT5 Forward ACGGATAGGATTGTTCCGGTTGC 97

[0245] Reverse TGTAGTCGCGTGGAAGAATCCG 98 CYP86A1 Forward GTTTACCTCAAGGCTGCTTTGGC 99

[0246] Reverse TGAAATCCTGAGGCACAGAAGG 100

[0247] G MYB41 Forward CCAGGGAGGACCGATAACGA 101

[0248] Reverse GGCGTGGAGAATGAGTAACAGG 102 Clathrin Forward AGCATACACTGCGTGCAAAG 103 AP4M Reverse TCGCCTGTGTCACATATCTC 104

[0249]

[0250] To refine this expression pattern, the inventors generated SBG1 : :NLS-3xmVenus transcriptional reporter lines. Promoter activity was initially detected in the columella and early endodermal lineage cells at the root tip (Figure 3g). In differentiated roots, SBG1 promoter activity was observed in primarily in the endodermis and to a lower extend in vascular tissues (Figure 3g). Following ABA treatment, promoter activity expanded into the early pericycle and endodermal cell lineages and was additionally detected in some epidermal and cortical cells in the elongation and early differentiation zones. Moreover, consistent with suberin-related genes such sMYB41, MYB92, and GPAT52,3, SBG1 promoter activity was further enhanced by ABA treatment, expanding toward the meristematic zone (Figure 3h).

[0251] The A. thaliana genome contains three uncharacterized homologs of SBG1 (referred to herein as SBGl-Likel, 2 and 3 or SBG1L1, SBG1L2 and SBG1L3) (Figure 7c). The protein sequences of SBG1, SBG1L1, SBGL2 and SBG1L3 were aligned with Clustal Omega methods on SnapGene (https: / / www.snapgene.com / ). The phylogenetic analysis was conducted on ClustalW2 with Phylip output format and Neighbour-joining clustering methods (https: / / www.ebi.ac.uk / idispatcher / phylogenv / simple phylogeny).

[0252] The quadruple sbgl;sbglll;sbgll2;sbgll3 (qiiad-sbgl) mutant exhibited a stronger reduction in suberin deposition compared to the single sbgl mutant (Figures 3i, j, and 7d).More strikingly, ABA-induced suberin deposition was progressively reduced in sbgl, sbgl, sbglll, and quad-sbgl mutants, suggesting that SBG1 and its homologs fine-tune ABA response in the root endodermis (Figures 3i and j).

[0253] To test this hypothesis, the inventors compared the transcriptional responses of Col-0 and sbgl roots to ABA by RNA-seq. Specifically, roots of 6-day-old seedlings were harvested and frozen by liquid nitrogen. The RNA extraction and purification were performed following the same protocol as for qRT-PCR. RNA samples were sent to Novogene for sequencing and analysis based on Illumina platform with Pair-end 150 bp strategy and 6 G data acquirement. After quality controls, high-quality reads were mapped to Arabidopsis thaliana TAIR10 genome with HISAT2 and the matrix of counts per gene was produced. The differential expression analysis was performed with DESeq2 and subjected for a multiple testing Benjamini and Hochberg correction with 5% FDR. For the GO enrichment analysis, all the genes with Padj <0.05 was selected and analysed on g:Profiler (https: / / biit.cs.ut.ee / gprofiler / gost).

[0254] Given the hypothesis that SBG1 acts as a local modulator of ABA-response in a limited number of endodermal cells, only subtle global transcriptional effects were expected. Consistent with this, under control conditions only minor expression differences was detected between sbgl and Col-0, with 29 genes upregulated and 45 downregulated, and no enrichment for specific biological processes. Next, ABA-induced genes in Col-0 and sbgl mutants were compared and striking differences were observed between genotypes with 4,689 genes affected in Col-0 and 7,449 in sbgl with only 59% shared with Col-0 (Figure 9) demonstrating that sbgl is affected in its ABA-response. Among the 268 genes induced by ABA in Col-0 but not in sbgl , as well as SBG1, so were several well-known ABA-responsive genes such as CBF3 (C-REPEAT BINDING FACTOR 3), ABF4 (ABRE BINDING FACTOR 4) and LEA4-1 (LATE EMBRYOGENESIS ABONDANT 4-1) (Figure 9). These results provide strong evidence that sbgl is affected in its transcriptional response to ABA.

[0255] Together, these results establish SBG1 as a positive regulator of endodermal suberization, possibly contributing to ABA-mediated suberin deposition.

[0256] Example 4 - SBG1 regulates suberin deposition in roots via interaction with Type One Protein Phosphatases (TOPPs)

[0257] The inventors assessed SBG1 subcellular localization with SBGl-mVenus and SBG1-mCherry fusion proteins, which exhibited a reticulated signal colocalizing with an ER marker (Figures5b and 6a)). Confocal microscopy imaging was used to analyse expression of fluorescent proteins using Leica SP8, Zeiss LSM 780, and Zeiss LSM 800 microscopes. Excitation and detection wavelengths may be set as follows: for Leica SP8 system, GFP / mVenus (488 nm, 500-546 nm), Pl / mCherry (552 nm, 585-617 nm); for Zeiss LSM 800, GFP / mVenus (488 nm, 500-546 nm), PI (561 nm, 585-617 nm); for Zeiss LSM 780 mVenus (514 nm, 515-561 nm), PI (514 nm, 585-679 nm). Scanner and detector settings may be maintained constantly across experiments to ensure consistency. Image analysis may be conducted using ZEN2.3 software (ZEISS) and Fiji25(http: / / fiii.se / Fiii).

[0258] Next, immunoprecipitation (IP) of SBG1 -mVenus from plants constitutively expressing the fusion protein was performed, followed by mass spectrometry (MS) analysis. Roots of 7-day-old seedlings expressing SBG1 -mVenus and ER-GFP were harvested for protein extraction. After grinding the total protein was extracted with 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 5 mM Dithiothreitol, 1 mM PMSF, 1% Triton X-100 and protease inhibitor cocktail (Roche). To immunoprecipitate mVenus or GFP tagged protein, GFP-Trap MagneticAgarose beads (Chromotek) were added to the supernatant of protein extracts. Beads were first washed 3 times with 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.01% Triton X-100, then 3 more times with 50 mM Tris-HCl pH 7.5, 150 mM NaCl. The beads were kept in the second washing buffer. To prepare samples for proteomic analysis, the remaining buffer was removed, and the beads were suspended in 100 pL 1 M Urea in 50 mM Ammonium bicarbonate. Samples were reduced using a final concentration of 10 mM DTT at RT for 30 min and alkylated with 20 mM iodoacetamide at RT for 30 min in the dark. Alkylation reactions were quenched with a half amount of DTT used for the reduction and incubated 10 min at RT in the dark. Finally, beads were incubated with 300 ng Trypsin (Promega, USA) in 1 mM chlorhydric acid and 25 mM ammonium bicarbonate and digested overnight at 25°C. Afterward, digestion was stopped by adding 10% TFA to reach a final concentration of 0.5%, centrifuged and deposited on a magnetic rack to transfer the supernatant into a fresh tube. Tryptic peptides were desalted using MonoSpin Cl 8 columns (GL Sciences Inc., Japan) and eluted from C18 columns using 0.1% TFA in 50% acetonitrile and dried in a centrifugal vacuum concentrator. Tryptic peptides were dissolved in 0.1% (v / v) formic acid in 2% (v / v) acetonitrile for mass spectrometry (MS) analysis.

[0259] For MS analysis, samples were measured on an Easy Nano LC Orbitrap Fusion System equipped with a nanospray flex™ ion source (Thermo Fisher Scientific, USA). Peptides were separated on a 1.9 pm particle, 75 pm inner diameter, 15 to 20 cm filling length homemade C18 column. A flow rate of 300 nL / min was used with a 2 h gradient 3-30% solvent B. The gradient followed with two rounds of washing steps, in each step, the gradient switched to 90% solvent B in 1 min and kept for another 5 min, and switched to 3% solvent B in 1 min and kept for another 5 min. In the second round of washing the 90% B solvent was kept for 2 min, an extra 14 min of 3% solvent B was kept for system equilibration. Solvent A was 0.1% (v / v) formic acid in LC / MS grade water and solvent B was 0.1% (v / v) formic acid in 100% (v / v) acetonitrile. The ion source settings from Tune were used for the mass spectrometer ion source properties. For data-independent acquisition (DIA), data were acquired with 1 full MS and 41 overlapping isolation windows constructed covering the precursor mass range of 350-1400 m / z. For full MS, Orbitrap resolution was set to 120,000. Automatic Gain Control (AGC) target was set to custom with normalized AGC target set to 50%, and maximum injection time (IT) was set to 100 ms. DIA segments were acquired at a resolution of 30,000. AGC target was set to custom with normalized AGC target set to 200%, and a 54 ms maximum IT. HCD fragmentation was set to normalized collision energy of 28%. For protein identification and quantification, Raw files from DIA measurements were analyzed using the directDIA workflow in Spectronaut software (Biognosys, Switzerland) with default settings. Identification was performed using the Uniprot reference proteome UP000006548 for Arabidopsis thaliana.

[0260] Enriched proteins were identified by comparison with an IP control from plants expressing ER-GFP. Among the most highly enriched proteins, two 2 Type One Protein Phosphatases (TOPPs): TOPP2 and TOPPl(Figure 5c). Notably, enrichment of TOPP7, TOPP8, TOPP4, and TOPP5 was also detected, meaning that 6 out of the 9 TOPPs present in 4. thaliana were enriched in the SBG1 IP -MS dataset (Figure 5c).

[0261] The interaction between SBG1 and TOPP2, the most strongly enriched phosphatase, was further validated by co-immunoprecipitation (Co-IP) in planta, using seedlings co-expressing SBGl-mVenus and TOPP2-mScarletI (Figure 6b). In particular,) assays, 7-day-old transgenic seedlings co-expressing SBGl-mVenus and CYP86Al-mScarletI or TOPP2-mScarletI were harvested and ground in liquid nitrogen. Total proteins were extracted with 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 5 mM Dithiothreitol, 1 mM PMSF, 1% Triton X-100 and protease inhibitor cocktail (Roche). After four centrifugations at 16,000 * g for 15 min at 4 °C,100 pL of the extracts was kept as input for the immunoblot. For immunoprecipitation the remaining supernatant was incubated for 2 h at 4°C with GFP-Trap Magnetic Agarose beads (Chromotek) with gentle rotation. Beads were then washed 3 times with 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.01% Triton X-100, then 3 more times with 50 mM Tris-HCl pH 7.5, 150 mM NaCl and eluted in 2x Laemmli buffer (100 pL buffer into 50 pL beads) by boiling for 5 minutes at 95°C. Input (25 pL, boiled in 2x Laemmli 5 minutes at 95 °C) and immunoprecipitated fractions (2 pL) were separated by SDS-PAGE and transferred to PVDF membranes. Immunoblots were probed with anti-GFP antibody (1:4000, JL-8, Clontech) or anti-RFP antibody (1:4000, 6G6, Chromotek) to detect mVenus and mScarletl respectively, followed by anti-mouse IgG (H+L) HRP-conjugated secondary antibodies (1:10000, W4021, Promega) and detection using SuperSignal West Femto Maximum Sensitivity Substrate (34095, Thermo Scientific). Signals were visualized with a ChemiDoc imaging system (Amersham Imager 680).

[0262] TOPPs are a family of serine / threonine phosphatases with broad functions in plants, including cell division, differentiation, salt tolerance and ABA signaling9. They are orthologs of Protein Phosphatase 1 (PPI) in animals and fungi, where their activity is modulated by regulatory subunits that interact through conserved RVxF and SILK motifs10. These regulatory interactions can either inhibit TOPPs activity by blocking substrate access (as seen for Inhibitor-2, 12) or recruit substrates while controlling access to the catalytic site (as observed for Kinetochore Null Protein 1, KNL1)9’11’12. SBG1 and SBG1L1 contain a SILK motif, while all 4 SBG1 homologs (SBG1, SBG1L1, SBG1L2, and SBG1L3) harbour an RVxF motif, suggesting a potential role in TOPP regulation (Figure 7c).

[0263] To assess this possibility, the inventors employed an in-silico structural approach using AlphaFold313, focusing on TOPP2, the most enriched phosphatase in the IP -MS dataset. Protein interaction between SBG1, SBG1L1, SBG1L2, SG1L3, 12 and TOPP2 was predicted by AlphaFold3 model (https: / / alphafoldserver.com / ). Full protein sequences of SBGls, 12, TOPP2 and 2x Mn2+were entered as input for the prediction, then final models were imported and modified with PyMOL V3.1.0 (https: / / www.pymol.org / ). A predicted local distance difference test (plDDT) showed high confident prediction with interface predicted template modeling (ipTM) of 0.85 and predicted template modelling (pTM) of 0.79, comparable to those observed for the well -characterized interactions between TOPP and 12 in 4. thaliana1214(Figures 4b and 5d-f). In this analysis, SBG1 was predicted to interact with TOPP2 via its central region, which contains both SILK and RVxF motifs (Figures 4b, 5d and e). Notably, a similar interaction was predicted for SBG1L1, which also harbours both the SILK and RVxF motifs (Figures 7c and 5f). In contrast, SBG1L2 and SBG1L3 contain only the RVxF motif, and their predicted interactions with TOPP2 only partially overlap with that of SBG1 (Figures 7c and 5f). Additionally, the C- termini of SBG1 homologs and the known TOPP inhibitor 12 are predicted to form similar structures covering over the TOPP2 catalytic site. This is particularly evident for SBG1 and SBG1L1, which possess extended C- terminal loops (Figure 5f), which suggest that SBG1 proteins may inhibit TOPP2 activity by sterically blocking access to its catalytic site in a similar way to 12. The differences in motif composition among SBG1 homologs and C termini provide a mechanistic rationale for their unequal genetic contributions. SBG1 and SBG1L1, the only family members containing both the SILK and RVxF motifs required for TOPP binding and an extended C-termini, contribute most strongly to the ABA-induced suberization response, whereas SBG1L2 and SBG1L3, lacking the SILK motif, have a weaker impact. This is reflected in the incremental phenotype of the quadruple mutant compared to the double mutant (Figure 3i), supporting a model in which SBG1 family members regulate suberization in proportion to their predicted ability to interact with TOPPs.To experimentally validate the interaction of SBG1 with TOPP1 and TOPP2, as well as the requirement of both SILK and RVxF motifs for SBG1 interaction with TOPP1 and TOPP2 TOPP, a yeast two-hybrid assay was performed. Yeast two-hybrid analyses were conducted using Matchmaker Gold Yeast Two-Hybrid System (Clontech; TaKaRa, Tokyo, Japan) according to the manufacturer's protocols. Yeast strain (Y2HGold) was co-transformed with the respective AD and BD plasmids and transformants were selected on SD-LW (leucine, tryptophane). For interaction analysis, 5 pl of yeast culture dilutions in the indicated concentration range were spotted on both SD-LW and SD-LWH (leucine, tryptophane, histidine) plates and incubated at 28°C for 3 days. The yeast two-hybrid assays confirmed that SBG1 interacts with both TOPP1 and TOPP2, and that the mutations SBG1 SM and SBG1 DM abolished these interactions (Figures 6d and 6e).

[0264] To test whether interaction with SBG1 affected TOPP2 activity, in vitro phosphatase assays using recombinant proteins were performed. Specifically, the phosphatase activity of TOPP2 with SBG1 was measured as previously described10, using the phosphorylated peptide H3pT3 (Histone 3 pT3: NH2-AR(pThr)KQTARKSTGGKAPRKQL-C00H, GenScript) as a substrate. Malachite Green reagent (MAK308, Sigma) was used to detect free Pi. Briefly, 25 pL of serially diluted SBG1 protein was mixed with 15 pL of 3.5 nM TOPP2 or reaction buffer (50 mM HEPES pH 8.0, 150 mM NaCl, 1 mM MnC12 and 1 mM DTT; low-signal control) in 96-well plate and incubated at room temperature for 30 min. Then, 10 pL of 500 pM H3pT3 peptide was added into SBG1-TOPP2 mixtures, followed by a 20-minute reaction at 30 °C. The reaction was terminated by addition of 50 pL Malachite Green reagent and after 30 min the absorbance at 620 nm was measured using a Tecan Spark plate reader.

[0265] Relative phosphatase activity was calculated by subtracting the background signal (low-signal control) and then normalizing resulting values to TOPP2 control where SBG1 was absent. IC50 curves were generated by fitting the data to a 4-parameter logistic model (Prism V10.6.1). In the phosphatase assays, SBG1 inhibited TOPP2 activity in a concentrationdependent manner, whereas SBG1-DM had no effect, demonstrating that the interaction is essential for inhibition (Figure 6f)

[0266] Furthermore, to detect protein complex formation, an analytic gel filtration assay was performed by mixing 100 pg of purified TOPP2 was mixed with either

[0267] 100 pg of wild-type or mutated SBG1 in a buffer containing 25 mM HEPES pH 8.0, 500 mM NaCl, 1 mM MnCh and 2 mM DTT. The protein mixture was incubated at 4 °C for 40 min followed by gel filtration on a Superose 63.2 / 300 column (GE Healthcare Life Sciences) in the same buffer. Fractions of eluted peaks were collected and analyzed by SDS-PAGE with Coomassie staining. In the assay, SBG1 co-eluted with TOPP2, confirming a direct physical interaction, while the double mutant version (SBG1-DM, mutated in both motifs) failed to bind (Figure 10a).

[0268] Next, the inventors examined whether allelic variation in SBG1 coding sequence could modulate this inhibitory effect. Comparison of the T and G alleles by AlphaFold prediction according to the methods described previously revealed no detectable differences in the predicted SBG1-TOPP2 interaction (Figure 10b). Consistently, in vitro phosphatase assays using recombinant proteins from the two allelic variants showed similar TOPP2 inhibition (Figure 6f). These findings reinforce the hypothesis that functional differences between alleles arise from regulatory variation in the 3’UTR rather than changes from the coding sequence. Together, these findings demonstrate that SBG1 physically interacts with TOPPs, particularly TOPP2, via conserved SILK and RVxF motifs, and acts as an inhibitory regulator of their phosphatase activity.TOPPs have not previously been implicated in suberin or polyester formation. However, previous studies showed that topp loss-of-function mutants are hypersensitive to ABA, and TOPP1 was reported to inactivate SNFl-related protein kinase 2.6 (SnRK2.6, also known as Open stomata, OST1), a key positive regulator of ABA signalling14,15. Consistently, SBG1-mVenus overexpressing lines, but not sbgl mutants, displayed ABA hypersensitivity comparable to previously described topp mutants (Figures 5g and h)15. This suggests that SBG1 may inhibit TOPP activity, thereby modulating ABA signalling. Suberin deposition in topp mutants was also examined and a significant increase in suberin levels with ectopic deposition near the root tip in the mutant topp2 was observed, a phenotype resembling UBQ1O::SBG1-mVenus overexpression lines and opposite to that of sbgl mutants (Figures 4e and 5i). This could indicate that SBG1 promotes suberization by antagonizing TOPP2 function in ABA signalling. Fitting with this hypothesis, T0PP2 promoter is active in the endodermis similar to SBG1 (Figure 4f). Figure 6h shows that SBG1 was not responsive to ABA, which was consistent with the RNA-seq analysis showing that T0PP2 transcript levels in roots are unaffected by ABA treatment.

[0269] To determine the genetic relationship between the SBG1 and TOPP2 genes, an epistasis analysis was performed. The double mutant sbgltopp2 displayed an ectopic suberization pattern indistinguishable from topp2 single mutants (Figure 6g), demonstrating that TOPP2 is epistatic to SBG1 and that SBG1 acts upstream of T0PP2 in this regulatory cascade. These findings support a model in which SBG1 inhibits TOPP2 activity, thereby alleviating its negative effect on ABA signalling and promoting suberization of endodermal cells.

[0270] To directly test this model, mutagenized SBGl-mVenus constructs lacking a functional RVxF motif or both SILK and RVxF motifs were generated and expressed constitutively. Unlike the WT SBGl-mVenus construct, both mutants (lacking either one or both motifs) failed to induce suberin deposition (Figures 4g and h). Moreover, both mutants showed reduced suberin induction in response to ABA, suggesting a partial dominant-negative effect. This confirms that SBGl’s positive role in suberization is mediated through its interaction with TOPPs.

[0271] Together, these results establish SBG1 as a key regulator of suberization, likely acting through inhibition of TOPP phosphatases, possibly by restricting their catalytic activity via direct protein-protein interaction. The in vitro analyses, confirm that SBG1 physically interacts with TOPP phosphatases (in particular TOPP2) and inhibits their phosphatase activity. Phylogenetic analysis of SBG1 proteins was also conducted on ClustalW2 with Phylip output format and Neighbour-joining clustering methods (https: / / www.ebi.ac.uk / jdispatcher / phylogeny / simple_phylogeny). Given the conservation of SBG1 across angiosperms (Figures 8a and b), this regulatory mechanism likely represents a fundamental and broadly relevant strategy for fine-tuning suberization.

[0272] DESCRIPTION OF THE SEQUENCES SEQ ID NO: 1 - Amino acid sequence of SBG1 protein MTCILSCSHGVVIATAMVFSSTALFLAISRQFSGNQTSDQQILRSCLSSEEKKKQRKNK KKKVKFAENVKETKGNGEEYRKKSLRRIVPEQMIKPEKTGSVCRNDMPANRIALYN GILRDRDHRIQCSY SEQ ID NO: 2 - SBG1 coding sequenceATGACTTGTATACTAAGCTGTTCTCATGGCGTCGTGATCGCAACCGCCATGGTTTT CTCAAGCACTGCTCTGTTTCTTGCGATTTCCCGCCAATTTTCTGGAAATCAGACAT CAGATCAACAAATCCTCCGTTCTTGTCTTTCTTCAGAGGAAAAGAAGAAACAGAG GAAGAATAAGAAGAAGAAAGTGAAATTTGCAGAGAATGTGAAAGAGACGAAAG GTAACGGTGAAGAGTATCGTAAGAAGAGTCTTCGGCGAATTGTACCGGAACAGA TGATTAAACCTGAGAAAACCGGTTCGGTTTGTAGAAACGACATGCCTGCTAACCG GATTGCATTGTACAATGGGATTCTTAGAGACAGAGATCATCGAATTCAGTGCTCC TATTGA SEQ ID NO: 3 - Polynucleotide sequence of the SBG1 gene from Col-0 Arabidopsis thaliana (capitalised letters represent nucleotides in the coding sequence) atctactttgttatttaaaaaccgtttctgattttctctaagaacagaaatgggaccggttacgaccaaaaaagcccatgtgtccagagtatt gtcgaattattagcttttggaccgaccttatccatctttggaccgttgttggcttttaagtgccctctcagtgtttttgttttattctcctttacattta accaaattaaatacttcaaaaactaattgtaagttaggttacggttagtaggtaagcttctggtgagaaaaaaagaaatagctaattagtaat acattatttctcccgattgtgtcaataagtttcgaacaagattgtccaaattacttccaaaacactgtgaacgatttttatttagtttggtatacat aacttaaaaaaatcagtgatatatgaatatgaagccgattagttttgaaatttagcatagttaattacaataatttagtcaaaatattagacaag aaacgtataattttcgattggaccgtcacgtggttttggcggttagcaatttggaccgccggtttgtttcgtttacagactacacagtgaccc attatggtttgttccggttcaccaaaccccacatgtggctagacttgagttaaaaattggtattggtcaaaatatggcttcttgtccaggagtc ttgtatttttctgcctcaatatatacaagaaacactcgattttgtaaagaatactaattactaacaattgatcattcacatgtctcatgtgttatct gttgaagccctaatctttttatatggtaaatgttatgctaaagactaaagttgtatcactgattatgtgtgcatgtctacttgtctagtcgttggtc gaatattcgaaatatatacaatcatgcttacactattcttcactttatgcaaaacattgattagatatataaaaaagccataataatattgtaaaa cttttattaaatttttatatgttataaacgacaaaaaaacagtatttggtaagactttagagtgataacacttgatcgtgaagttttcgacgttata actagaattttggactcttaacaagaattttataatatcttgatggttccacaaacataaaatcatatctctatacaaagattctcaaatttgata gcattaatttaatttttctgataacagtatttttttttcttttcttaagtcttaatcttgattaaaaacataatttcgctgatttttaaccttttaaacatat aaaaatatgttttttcatgtgggagaaaagttataataatcaaatgtagaaagagtcttttaaatttcttactcttttcttgtcgctaaaaactctat ttagtatttttcacatgtcaatcacctaaaattacatacagagaatcatccgaaaagctaattgtgattatctacaataattaattataattacttt tcttttcatttctacattttcatagttgctggtaaagaagaaaaggaaaaaaagT C A AT AGGAGC AC T GA ATTC GAT GATCTCTGTCTCTAAGAATCCCATTGTACAATGCAATCCGGTTAGCAGGCATGTC GTTTCTACAAACCGAACCGGTTTTCTCAGGTTTAATCATCTGTTCCGGTACAATTC GCCGAAGACTCTTCTTACGATACTCTTCACCGTTACCTTTCGTCTCTTTCACATTCT CTGCAAATTTCACTTTCTTCTTCTTATTCTTCCTCTGTTTCTTCTTTTCCTctgcatcaaaa attattcttagccggaggatgatcggagaagaaagatcggaaaagggtacCTGAAGAAAGACAAGAACGGAGG ATTTGTTGATCTGATGTCTGATTTCCAGAAAATTGGCGGGAAATCGCAAGAAACA GAGCAGTGCTTGAGAAAACCATGGCGGTTGCGATCACGACGCCATGAGAACAGC TTAGTATACAAGTCATSEQ ID NO: 4 - Polynucleotide sequence of the SBG1 gene from Tsu-0 Arabidopsis thaliana (capitalised letters represent nucleotides in the coding sequence)

[0273] atctactttgttatttaaaaaccgtttctgattttctctaagaacaaaaatgggaccggttacgaccaaaaaagcccatgtgtccagagtatt gtcgaattattagcttttggaatttggaccgaccttatccctctttggaccgttgttggctttttagtgcctctcagtgtttttgttttattctccttta catttaaccaaattaaatacttcaaaaactaattgtaagttaggttacggttagtaggtaagcttctggtgagaaaaaaagaaatagctaatt agtaatacattatttctcccgattgtgtcaataagtttcgaacaagattgtccaaattacttccaaaacactgagaacgatttttatttagtttga tacacataacttaaaaaaatcagtaatatatgaatatgaagtcgattagttttgcaatttagcatagttaaatgcaataatttagtcaaaaatat aagtattagacacgaaacgtataatttgggtggaccgtcacgtggttttggcggttagcaatttggaccgtcggtttgtttcgtttacagact acacagtggcccattatggtttgttccggttcaccaaaccccacatgtggctagacttgagttaaaaattggtattggtcaaatatggcttct tgaccaggaggagtcttgtattttttctgcctcaataaattcaagaaatactcgattttgtaaagaatactaattactaacaattgatcattcac atgtctcatgtgttacctgttgaagccctaatctttttatatggtaaatgttatgctaaagactaaagttgtatcactgattatgtgtgcatgtcta cttgtctagtcgttggtcgaattttcgaaatatatacaatcatgcttacactattcttcactttatgcaaaacattgattagataaaaaaaaaag ccataataatagtgtaatacctttattaaaaaaaaaaacagtatttggtaagactttagagtgataacacttggacttgatcatgaagttttcg acgttttaactagaaatttggactcttaactagaattttataatatattgatggttccacaaacataaaatcatatctctatacaagattctcaaat ttgatagcattaattctgataatagtatttaatgttttcttttcttaagtcttaatcttcttaccagttgattaaaaacataatttcgctgatttttaacc ttttaaacatataaaaatatggggttttcatttcggagaaaagttataataatcaaatgtgaaaagagtcttttaaatttcatactcttttcttgtc gctaaaaactctatttcacatgtcaatcacctaaaattacatacagagaatcatccgaaaagctaactgtgattatctacaataattaattata attacttttcttttcatttctacattttcatagttgctggtaaagaagaaaatgaaaaaaaaaaaagT C AAT AGGAGC ACTGA ATTCGATGATCTCTGTCTCTAAGAATCCCATTGTACAAAGCAATCCGGTTAGCAG GCATGTCGTTTCTACAAACCGAACCGGTTTTCTCAGGTTTAATCATCTGTTCCGGT ACAATTCTCCGAAGACGTTGTTCCCTCTTCTTACGATACTCTTCACCGTTACCTTTC GTCTCTTTCACATTCTCTGCAAATTTCACTTTCTTCTTCTTATCCTTCCTCTGTTTCT TCTTTTCCTctgcatcaaaaaatattcttagccggaggatgatcggagaagaaagatcggaaaagggtacCTGAAGAA AGACAAGAACGGAGGATTTGTTGATCTGATGTCTGATTTCCAGAGAATTGGCGGG AAATCGCAAGAAACAGAGCAGTGCTTGAGAAAACCATGGCGGTTGCGATCACGA CGCCATGAGAACAGCTTAGTATACAAGTCAT SEQ ID NO: 5 - SBG1L1 coding sequence ATGTTGAGCTGTTCTAATGGTACCGTCGTGATCGCAACCGCCATGGTTTGCTCAA GCACCGCTCTGTTTCTCGCCATGGCTCGTCAATTCCATGGAAATCATCAAAATCCT AAGGTTCTTGATCAGACTCTACGACCCATTCTCCGTTCTTGTCTATCTTCAGAGGA AACGAAGAAACAGGGGAAGAAGATAAAGAAAGTGCGGTTCGCGGATAATGTGA AAGATACGAAAGGTAACGGGGAAGAGTACCGGAGGAGGGAATTGAACCGGAAA AGCGTACCGAAGCCAGTGACTAAACCGGGAAAGACCGGTTCTATGTGTAGAATC TCTACCATGCCAGCGAACCGGATGGCTCTGTACAATGGGATTCTTAGAGACCGAG ATCACAGAGTTCAATATTCTTATTGA SEQ ID NO: 6 -SBG1L2 coding sequence ATGGAGAGCTCAATTGGGTTCATGACAGTCTTCGCCGTCTCTGGAAGCGTGGTGC TTCTTGCAGCTCAGCTTCACAAGCGTCTCCTCTCTGGTTACATGGACAAGCTCGAA CCTCCTACTAAGGAAAGAAAGAAAAAGAAAAAGAAAGTGAGCTTTGCAGAAGAT ATGGTGGAGCCGTCAGGGAACAACGAAGAGTATCGCCGGAGTTTTCGCAAATCA TCAAAGTTGGAGGATGAAAGATGASEQ ID NO: 7 SBG1L3 coding sequence ATGGAGAGTTCATTAGGTTTCATGGCGGTTTTCGCCGTCTCAGGAAGCGTTGTGTT CTTAGCGAGTCAATTTCACAAGCGTCTTCTCTCCGATTACATGGACAAGTTCGAAT TCGAAATCCGAGCGCAGAAAAAAATGGTGATGAAGAAGAAGGTGAGATTCGCGG CGGATGTGGTGGAGCCGTCGGGGAATAACAAAGAGTATCGCCGGAGACATTCTT CCAAGGCTAAATCGAATTCGAAGATGGCGGCAACTATTTGA SEQ ID NO: 8 - Amino acid sequence of SBG1L1 protein MLSCSNGTVVIATAMVCSSTALFLAMARQFHGNHQNPKVLDQTLRPILRSCLSSEET KKQGKKIKKVRFADNVKDTKGNGEEYRRRELNRKSVPKPVTKPGKTGSMCRISTMP ANRMALYNGILRDRDHRVQYSY SEQ ID NO: 9 - Amino acid sequence of SBG1L2 protein MESSIGFMTVFAVSGSVVLLAAQLHKRLLSGYMDKLEPPTKERKKKKKKVSFAEDM VEPSGNNEEYRRSFRKSSKLEDER SEQ ID NO: 10 - Amino acid sequence of SBG1L3 protein MESSLGFMAVFAVSGSVVFLASQFHKRLLSDYMDKFEFEIRAQKKMVMKKKVRFAA DVVEPSGNNKEYRRRHSSKAKSNSKMAAT SEQ ID NO: 11 - Amino acid sequence of the SBG1 ortholog in Cucumis melo MSSILSSQGLVIATAMVVSSTALFLAFSNHHHKMISPIIPPSTSLLPSCFSSDEKKKQKK KKKVRFAEDVKEPKGNGEEYRREHDEKIGLMEETRRGRRISCRNDIPANRIALYNGIL KDRSQRIQCSF SEQ ID NO: 12 - Amino acid sequence of the SBG1 ortholog in Populus trichocarpa MSSKLTSQGVVLATVMAVSSTVVFLAFSKQKTLPHQVLSESRDSESPTPSQDLRSCLS TEGKRKKKRVQFAENVKNTKGNGDEYRRERQNPWITRREREVSNTRMSRVCRNEIQ GNHGMPENRVALYSGILVDRVHKMEC SEQ ID NO: 13 - Amino acid sequence of the SBG1 ortholog in Vitis vinifera MSSILCSQGVVLATAMAVSGILFLAFSRQKSLPSPEFSGNPNSQAPKQILRSCLTNDEK KRERKKKRVQFAENVKEPSGNGKEFRQEQRKKFSRVQRPCRNEIPQIQKVPENQAAL YNGILRDR VHRM AC SY SEQ ID NO: 14 - Amino acid sequence of the SBG1 ortholog in Solanum lycopersicum MSSMLGSQGFVLATAMAVSAGTVILLDLFRVKYFPATHLSDQQQDYPHNEKQILKSC LS S AGKKKDKTRKKKKKVQF AAD VKS S SGNGEEYRRKQMRKFTESRIKSCGNEIVG MPGNRMALYTGILKDRVQRMGFSHSEQ ID NO: 15 - Amino acid sequence of the SBG1 ortholog in Zea mays MS S SS SMGGSLAL AAATAVALSGSLVIF SLCRAHLAHGAEPEPEPEHALRPCLS S SER RTRGGGKAKARRRKGERRVRFAADVVDNEGATRPVRFSPPAPSSSAATCGDAARSE DPMMPANREALYRGMLRDRSTHRVTCSY SEQ ID NO: 16 - Amino acid sequence of the SBG1 ortholog in Oryza sativa

[0274] MS S S S S S AGGSHAGL AL AAT AMAL SGTL VLF SLCRANKPPHHDD AP ARLRPCLS S SE KRKREKARRGSKKRVRFAADVVDNDSNASSRPAAAEPSCRNAAATAATAMPANRE ALYRGMLRGRSMLRVACSY SEQ ID NO: 17 - Amino acid sequence of the SBG1 ortholog in Brachypodium distachyon MALSGSLVLFSLRRFAKPAEHDDDVPASPASLRPCLSSSSSNSERRPRRKGEKKRVRF A AG V VDNEG A APP VARS S S S ARP SP SEPTCRGS AGGDHHRMP ANREALYRGMLRDR SVHRTAYSY SEQ ID NO: 18 - Amino acid sequence of the SBG1 ortholog in Lotus japonicus MASSISHGLVLTTAMVFSATVLYLAFSQTPHSNQPILRSCLCSEEKKKEMKRKKKRV KFAKNVMVKVVLKEEETDINDEIGEEQGKKKKKNRAS S S SIS SNCRNENPESRGNGM PANRMALYNGILRDRGNRVACCH SEQ ID NO: 19 - Amino acid sequence of the SBG1 ortholog in Medicago truncatula MTSLSQGLVFTTAMLVSSTMLYLAFSKHKINPSFQILGSHVSHDPHTQILRSCLYSEEK KRERKMNSKKNKKKVRFEESVKESREKSEVAKKEKQRKRNRVHSNCRSEATKTRGI PANRMALYNGILRDRVHRIE SEQ ID NO: 20 - Amino acid sequence of the SBG1 ortholog in Glycine max MASSISQGLVFTTAMLVSTTVLYLAFSRQKTSPPFQISQNSNSLHSNKKILRSCIYSEEK

[0275] I<RERI<I<NI<I<I<VI<FAENVMVI<EVERVSNEI<NREI<QGRQNRVSLSSNECRSEIPI<I<HE MPANRIALYNGILRDRVHRMSCCH SEQ ID NO: 21 - Amino acid sequence of the SBG1 ortholog in Cicer arietinum MASSISQGLVFTTAMLVSTTVLYLAFSRQKTSPPFQISQNSNSLHSNKKILRSCIYSEEK

[0276] I<RERI<I<NI<I<I<VI<FAENVMVI<EVERVSNEI<NREI<QGRQNRVSLSSNECRSEIPI<I<HE MPANRIALYNGILRDRVHRMSCCH SEQ ID NO: 22 - Amino acid sequence of the SBG1 ortholog in Cucumis sativus MSSILSSQALVLATAMVVSSTALFLAFSNHHHKMINPTIPPSTSLPPCFSSDEKKKQRN KKKKKKKVRFAEDVKEPKGNGEEYRREHDEKMGLMEETRRRRRISCRNDVPGNRIA LYNGILKDRSQRIQCSFSEQ ID NO: 23 - Amino acid sequence of the SBG1 ortholog in Hordeum vulgare

[0277] MS S S S S S SGGAGS ALGGSHAGL AL A ATAMAL SGTL VLF SLCRAKQTDHHLL S SD AAV TSPSPARLRPCLSSSEKRKREKARRGSMKRVRFAADVVDHGPARPAPEEETAAPEPSC RGAAMP ANREALYRGMLRGRSMLRT AC SY SEQ ID NO: 24 - Amino acid sequence of the SBG1 ortholog in Beta vulgaris MSSIIGSQGVFLATAMAAVSGTVILLAFKLQKSNLFPSNSHFQVNSIPILRPCLSSGEKK AEI<I<I<I<I<VRFAEDVVDPRGDNEEFRI<QHSNNILRI<ISI<VENRGMPANRLALYI<GIIR DRVIHRITYSY SEQ ID NO: 25 - Amino acid sequence of the SBG1 ortholog in Daucus carota

[0278] MS SILNS S S VVL ATAMAVSGT VIVLAFRLQKLTS VTSPSLPRSCIS SDEKKKDRKKKK KVHFAEDVMDPIGNSEDFRKKLLLRSYKPAPARKMPANRTALYAGILRDRVVINRPT YSC SEQ ID NO: 26 - Amino acid sequence of the SBG1 ortholog in Selaginella moellendorffii MAKLTPGIVAVIMVSGSVIYIAANRFHRLKQQNFEDLAPAAKPKKKVRFSDSVVEPK GDNREFRRSRKARGSVNQEISDQGGEPAPAPSAAPEISVDRAPPPGDHRPISKKVEALL GSNLPANRIALYSDRYHDRLLKV SEQ ID NO: 27 - Amino acid sequence of the SBG1 ortholog in Taxus chinensis MEGSGGGGMGILTVIMVSGGVALLVLGRHKLPELNLIKPIPSKSFSGRSCLSSANNLR RKKNKKRVRF AAEVVEHDQIQQKQKQKIRES SIP ANNGRP VEERS SIP ANRLALYNG MLRYRMHQASLYR SEQ ID NO: 28 - Amino acid sequence of the SBG1 ortholog in Amborella trichopoda MGFALSSQGGVVLAAAMAFSGTMILLNSHRKKLFDESLANLRPCISSQDKRREGEKK

[0279] I<QI<I<I<I<MMMRI<RVHFAEDVMEPI<GDSI<EFRRI<HTMAPALRIHENI<REINI<I<SAIN EVSNMPANWRALYSGILRDRSQRMACMY SEQ ID NOs: 29-68 - Genotyping primers (see Table 1)

[0280] SEQ ID NOs: 69-76 - CRISPR primers (see Table 2)

[0281] SEQ ID NOs: 77-94 - Cloning primers (see Table 3)

[0282] SEQ ID NOs: 95-104 - Quantitative PCR (qPCR) primers (see Table 4)

[0283] SEQ ID NOs: 105-109 - CRISPR-induced mutations in SBG1 generated in Leo-1 and Tsu-0 backgrounds (see Figure 4g)SEQ ID NOs: 110-111 - CRISPR-induced mutation in SBG1 to generate the sbgl-2 allele in the Col-0 background (see Figure 7a)

[0284] SEQ ID NOs: 112-118 - CRISPR-induced mutations in SBG1L1, SBG1L2 and SBG1L3 to generate the sbgl-l;sbglll double mutant and the sbgl-l;sbglll;sbgll2;sbgll3 quadruple mutants in the Col-0 background (see Figure 7c)

[0285] SEQ ID NO: 119 - Consensus sequence of SBG1, SBG1L1, SBG1L2 and SBG1L3 protein alignments (see Figure 7d)

[0286] SEQ ID NOs: 120-138 - Alignments of the SBG1 protein from A. thaliana and its orthologs from other 18 plant species (see Figure 8a)

[0287] SEQ ID NO: 139 - SBG1L3 amino acid sequence (see Figure 7d)

[0288] REFERENCES

[0289] 1. Shukla, V. & Barberon, M. Building and breaking of a barrier: Suberin plasticity and function in the endodermis. Curr Opin Plant Biol 64, 102153 (2021). https: / / doi.Org / 10.1016 / j.pbi.2021.102153

[0290] 2. Barberon, M. et al. Adaptation of Root Function by Nutrient-Induced Plasticity of Endodermal Differentiation. Cell 164, 447-459 (2016). https: / / doi.Org / 10.1016 / j.cell.2015.12.021

[0291] 3. Shukla, V. et al. Suberin plasticity to developmental and exogenous cues is regulated by a set of MYB transcription factors. Proc Natl Acad Sci U S A 118 (2021). https: / / doi.org / 10.1073 / pnas.2101730118

[0292] 4. Kosma, D. K. et al. AtMYB41 activates ectopic suberin synthesis and assembly in multiple plant species and cell types. The Plant Journal 80, 216-229 (2014).

[0293] 5. Xu, H. et al. Transcriptional networks regulating suberin and lignin in endodermis link development and ABA response. Plant Physiol 190, 1165-1181 (2022). https: / / doi.org / 10.1093 / plphys / kiac298

[0294] 6. Seren, U. in Root Development: Methods and Protocols (eds Daniela Ristova & Elke Barbez) 303-319 (Springer New York, 2018).

[0295] 7. Gully, K. et al. The GPAT4 / 6 / 8 clade functions in Arabidopsis root suberization nonredundantly with the GPAT5 / 7 clade required for suberin lamellae. Proc Natl Acad Sci U S A 121, e2314570121 (2024). https: / / doi.org / 10.1073 / pnas.23145701218. Yadav, V. et al. ABCG Transporters Are Required for Suberin and Pollen Wall Extracellular Barriers in Arabidopsis. Plant Cell 26, 3569-3588 (2014).

[0296] 9. Uhrig, R. G., Labandera, A. M. & Moorhead, G. B. Arabidopsis PPP family of serine / threonine protein phosphatases: many targets but few engines. Trends Plant Sci 18, 505-513 (2013). https: / / doi.Org / 10.1016 / j.tplants.2013.05.004

[0297] 10. Srivastava, G., Choy, M. S., Bolik-Coulon, N., Page, R. & Peti, W. Inhibitor-3 inhibits Protein Phosphatase 1 via a metal binding dynamic protein-protein interaction. Nature Communications 14, 1798 (2023). https: / / doi.org / 10.1038 / s41467-023-37372-5

[0298] 11. He, Y. et al. Arabidopsis KNL1 recruits type one protein phosphatase to kinetochores to silence the spindle assembly checkpoint. Sci Adv 11, eadq4033 (2025). https: / / doi.org / 10.1126 / sciadv.adq4033

[0299] 12. Templeton, George W. et al. Identification and characterization of AtI-2, an Arabidopsis homologue of an ancient protein phosphatase 1 (PPI) regulatory subunit. Biochemical Journal 435, 73-83 (2011). https: / / doi.org / 10.1042 / bj20101035

[0300] 13. Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493-500 (2024). https: / / doi.org / 10.1038 / s41586-024-07487-w 14. Hou, Y.-J. et al. Type One Protein Phosphatase 1 and Its Regulatory Protein Inhibitor 2 Negatively Regulate ABA Signaling. PLOS Genetics 12, el005835 (2016). https: / / doi.org / 10.1371 / journal.pgen.1005835

[0301] 15. Zhang, J. et al. Role of Protein Phosphatasel Regulatory Subunit3 in Mediating the Abscisic Acid Response Plant Physiology 184, 1317-1332 (2020). https: / / doi.org / 10.1104 / pp.20.01018

[0302] 16. Ristova, D., Giovannetti, M., Metesch, K. & Busch, W. Natural genetic variation shapes root system responses to phytohormones in Arabidopsis. The Plant Journal 96, 468-481 (2018). https: / / doi.Org / https: / / doi.org / 10.l 111 / tpj.14034

[0303] 17. Alonso-Blanco, C. et al. 1,135 Genomes Reveal the Global Pattern of Polymorphism in Arabidopsis thaliana. Cell 166, 481-491 (2016). https: / / doi.Org / http: / / dx.doi.org / 10.1016 / j.cell.2016.05.063

[0304] 18. Kover, P. X. et al. A Multiparent Advanced Generation Inter-Cross to Fine-Map Quantitative Traits in <italic> Arabidopsis thaliana< / italic>. PLoS Genet 5, el000551 (2009). https: / / doi.org / 10.1371 / journal.pgen.100055119. Lin, R. & Wang, H. Arabidopsis FHY3 / FAR1 Gene Family and Distinct Roles of Its Members in Light Control of Arabidopsis Development. Plant Physiology 136, 4010-4022 (2004). https: / / doi.org / 10.1104 / pp.104.052191

[0305] 20. Fauser, F., Schiml, S. & Puchta, H. Both CRISPR / Cas-based nucleases and nickases can be used efficiently for genome engineering in rabidopsis thaliana. The Plant Journal 79, 348-359 (2014). https: / / doi.Org / https: / / doi.org / 10.llll / tpj.12554

[0306] 21. Ursache, R., Fujita, S., Denervaud Tendon, V. & Geldner, N. Combined fluorescent seed selection and multiplex CRISPR / Cas9 assembly for fast generation of multiple Arabidopsis mutants. Plant Methods 17, 111 (2021). https: / / doi.org / 10.1186 / sl3007-021-00811-9

[0307] 22. Kalmbach, L. et al. Putative pectate lyase PLL12 and callose deposition through polar CALS7 are necessary for long-distance phloem transport in Arabidopsis. Current Biology 33, 926-939. e929 (2023). https: / / doi.Org / https: / / doi.org / 10.1016 / j.cub.2023.01.038

[0308] 23. Clough, S. J. & Bent, A. F. Floral dip: a simplified method for Agrobacterium -mediated transformation ofArabidopsis thaliana. The Plant Journal 16, 735-743 (1998). https: / / doi.Org / 10.1046 / j.1365-313x.1998.00343.x

[0309] 24. Shimada, T. L., Shimada, T. & Hara-Nishimura, I. A rapid and non-destructive screenable marker, FAST, for identifying transformed seeds of Arabidopsis thaliana. Plant J 61, 519-528 (2010).

[0310] 25. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nature Methods 9, 676-682 (2012). https: / / doi.org / 10.1038 / nmeth.2019

[0311] 26. Ferrero-Serrano, A. & Assmann, S. M. Phenotypic and genome-wide association with the local environment of Arabidopsis. Nat Ecol Evol 3, 274-285 (2019). https: / / doi.org / 10.1038 / s41559-018-0754-5

[0312] 27. Berhin, A. et al. The Root Cap Cuticle: A Cell Wall Structure for Seedling Establishment and Lateral Root Formation. Cell 176, 1367-1378. el368 (2019). https: / / doi.Org / 10.1016 / j.cell.2019.01.005

[0313] 28. Horton, M. W. et al. Genome-wide patterns of genetic variation in worldwide Arabidopsis thaliana accessions from the RegMap panel. Nat Genet 44, 212-216 (2012). https: / / doi.Org / http: / / www.nature.com / ng / journal / v44 / n2 / abs / ng.1042. html#supplementary-information29. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25, 402-408 (2001). https: / / doi.org / 10.1006 / meth.2001.1262.

[0314] EMBODIMENTS

[0315] 1. A method of increasing suberin deposition in the root of a plant, the method comprising increasing the level or activity of an SBG1 protein or a homolog or ortholog thereof in a plant.

[0316] 2. The method of embodiment 1, wherein increasing suberin deposition in the root of the plant increases the fitness of the plant, optionally wherein the increase in fitness is an increase in plant biomass, an increase in root growth, an increase in water use efficiency, an increase in stress tolerance, and / or an increase in carbon sequestration capacity, optionally wherein the stress is a biotic stress and / or an abiotic stress, optionally wherein:

[0317] (a) the biotic stress is pathogen-induced stress, weed-induced stress, and / or pest-induced stress; and / or

[0318] (b) the abiotic stress is drought stress, salt stress, stress induced by exposure to toxic elements, stress induced by exposure to heavy metals, oxidative stress, waterlogging stress, and / or nutrient deficiency stress.

[0319] 3. The method of any preceding embodiment, wherein the method comprises introducing into the plant a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof, optionally wherein the polynucleotide further comprises a promoter operatively linked to the sequence encoding the SBG1 protein or homolog or ortholog thereof, optionally wherein the promoter is a heterologous promoter, optionally wherein the heterologous promoter is a constitutive promoter, a tissue-specific promoter, or an inducible promoter, optionally wherein the promoter is UBQ10 or CaMV35S and / or wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28, optionally wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises an amino acid sequence selected from any of SEQ IDNOs: 1 or 8-28.4. A polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof.

[0320] 5. The polynucleotide of embodiment 4, wherein the polynucleotide encodes a protein comprising an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28, optionally wherein the polynucleotide encodes a protein comprising the amino acid sequence of any of SEQ ID NOs: 1 or 8-28; and / or wherein the polynucleotide further comprises a promoter, optionally wherein the promoter is a heterologous promoter, optionally wherein the heterologous promoter is a constitutive promoter, a tissue-specific promoter, or an inducible promoter, optionally wherein the promoter is UBQ10 or CaMV35S and / or comprising a polynucleotide sequence having at least 60% sequence identity to any of SEQ ID NOs 2-7, optionally comprising a polynucleotide sequence selected from any of SEQ ID NOs: 2-4; and / or wherein the polynucleotide is an isolated polynucleotide.

[0321] 6. A vector comprising the polynucleotide of embodiment 4 or 5.

[0322] 7. A cell comprising the polynucleotide of embodiment 4 or 5, or the vector of embodiment 6, optionally wherein the cell is a plant cell.

[0323] 8. A plant or part thereof comprising the polynucleotide of embodiment 4 or 5, the vector of embodiment 6, or the cell of embodiment 7, optionally wherein the plant is not exclusively obtained by means of an essentially biological process.

[0324] 9. Use of the polynucleotide of embodiment 4 or 5, the vector of embodiment 6, or the cell of embodiment 7 for increasing suberin deposition in the root of a plant.

[0325] 10. The use of embodiment 9, wherein increasing suberin deposition in the root of the plant increases the fitness of the plant, optionally wherein the increase in fitness is an increase in plant biomass, an increase in root growth, an increase in water use efficiency, an increase in stress tolerance, and / or an increase in carbon sequestration capacity, optionally wherein the stress is a biotic stress or an abiotic stress, optionally wherein:

[0326] (a) the biotic stress is pathogen-induced stress, weed-induced stress, and / or pest-induced stress; or(b) the abiotic stress is drought stress, salt stress, stress induced by exposure to toxic elements, stress induced by exposure to heavy metals, oxidative stress, waterlogging stress, and / or nutrient deficiency stress.

[0327] 11. A method of producing a plant having increased root suberin deposition, the method comprising introducing into the plant a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof as defined in embodiment 4 or 5.

[0328] 12. The method of embodiment 11, wherein the polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof is introduced into the plant by direct gene transfer, microinjection, transformation and / or virus-mediated methods, optionally wherein the method of transformation is Agrobacterium tumefaciens-mediated transformation; and / or wherein:

[0329] (a) the polynucleotide further comprises a promoter, optionally wherein the promoter is a heterologous promoter;

[0330] (b) the heterologous promoter is a constitutive promoter, a tissue-specific promoter or an inducible promoter;

[0331] (c) the constitutive promoter is UBQKk or CaMV35S

[0332] (d) the polynucleotide encodes an SBG1 protein or a homolog or ortholog thereof comprising an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28, optionally wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises the amino acid sequence of any of SEQ ID NOs: 1 or 8-28; and / or

[0333] (e) the polynucleotide sequence comprises a polynucleotide sequence having at least 60% sequence identity to any of SEQ ID NOs 2-7, optionally comprising a polynucleotide sequence selected from any of SEQ ID NOs: 2-4.

[0334] 13. A method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof as defined in embodiment 4 or 5 into a plant, the method comprising:

[0335] (i) crossing a first plant comprising a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof with a second plant lacking a native polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof so as to produce a population of offspringcomprising said polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof; and

[0336] (ii) selecting offspring comprising the polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof, optionally wherein: the polynucleotide introgressed into the offspring further comprises a promoter, optionally wherein the promoter is heterologous promoter, optionally wherein the heterologous promoter is a constitutive promoter, a tissuespecific promoter, or an inducible promoter, optionally wherein the promoter is UBQ10 or CaMV35S,' and / or wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28, optionally wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises the amino acid sequence of any of SEQ ID NOs: 1 or 8-28; and / or wherein the polynucleotide sequence comprises a polynucleotide sequence having at least 60% sequence identity to any of SEQ ID NOs 2-7, optionally comprising a polynucleotide sequence selected from any of SEQ ID NOs: 2-4.

[0337] 14. A plant or plant cell obtainable by the method of any of embodiments 11 to 13.

[0338] 15. The method or plant or plant cell of any preceding embodiment, wherein the plant is a monocotyledonous plant or a dicotyledonous plant; and / or wherein the plant is selected from the group consisting of Arabidopsis thaliana, Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza sativa, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza sativa, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda.

Claims

CLAIMS1. A method of increasing suberin deposition in the root of a plant, the method comprising increasing the level or activity of an SBG1 protein or a homolog or ortholog thereof in a plant.

2. The method of claim 1, wherein increasing suberin deposition in the root of the plant increases the fitness of the plant.

3. The method of claim 2, wherein the increase in fitness is an increase in plant biomass, an increase in root growth, an increase in water use efficiency, an increase in stress tolerance, and / or an increase in carbon sequestration capacity.

4. The method of claim 3, wherein the stress is a biotic stress or an abiotic stress.

5. The method of claim 4, wherein the biotic stress is pathogen-induced stress, weed-induced stress, and / or pest-induced stress.

6. The method of claim 4, wherein the abiotic stress is drought stress, salt stress, stress induced by exposure to toxic elements, stress induced by exposure to heavy metals, oxidative stress, waterlogging stress, and / or nutrient deficiency stress.

7. The method of any preceding claim, wherein the method comprises introducing into the plant a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof.

8. The method of claim 7, wherein the polynucleotide further comprises a promoter operatively linked to the sequence encoding the SBG1 protein or homolog or ortholog thereof, optionally wherein the promoter is a heterologous promoter.

9. The method of claim 8, wherein the heterologous promoter is a constitutive promoter, a tissue-specific promoter, or an inducible promoter.

10. The method of claim 9, wherein the promoter is UBQ10 or CaMV35S.

11. The method of any of claims 7 to 10, wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28.

12. The method of claim 11, wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises an amino acid sequence selected from any of SEQ ID NOs: 1 or 8-28.

13. A polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof.

14. The polynucleotide of claim 13, wherein the polynucleotide encodes a protein comprising an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28.

15. The polynucleotide of claim 14, wherein the polynucleotide encodes a protein comprising the amino acid sequence of any of SEQ ID NOs: 1 or 8-28.

16. The polynucleotide of any of claims 13 to 15, wherein the polynucleotide further comprises a promoter, optionally wherein the promoter is a heterologous promoter.

17. The polynucleotide of claim 16, wherein the heterologous promoter is a constitutive promoter, a tissue-specific promoter, or an inducible promoter.

18. The polynucleotide of claim 17, wherein the promoter is UBQ10 or CaMV35S.

19. The polynucleotide of any of claims 13 to 18, which comprises a polynucleotide sequence having at least 60% sequence identity to any of SEQ ID NOs 2-7, optionally comprising a polynucleotide sequence selected from any of SEQ ID NOs: 2-4.

20. The polynucleotide of any of claims 13 to 19, wherein the polynucleotide is an isolated polynucleotide.

21. A vector comprising the polynucleotide of any of claims 13 to 19.

22. A cell comprising the polynucleotide of any of claims 13 to 19, or the vector of claim 21.

23. The cell of claim 22, wherein the cell is a plant cell.

24. A plant or part thereof comprising the polynucleotide of any of claims 13 to 19, the vector of claim 21, or the cell of claim 22 or 23.

25. The plant or part thereof of claim 24, wherein the plant is not exclusively obtained by means of an essentially biological process.

26. Use of the polynucleotide of any of claims 13 to 19, the vector of claim 21, or the cell of claim 22 or 23 for increasing suberin deposition in the root of a plant.

27. The use of claim 26, wherein increasing suberin deposition in the root of the plant increases the fitness of the plant.

28. The use of claim 27, wherein the increase in fitness is an increase in plant biomass, an increase in root growth, an increase in water use efficiency, an increase in stress tolerance, and / or an increase in carbon sequestration capacity.

29. The use of claim 28, wherein the stress is a biotic stress or an abiotic stress.

30. The use of claim 29, wherein the biotic stress is pathogen-induced stress, weed-induced stress, and / or pest-induced stress.

31. The use of claim 29, wherein the abiotic stress is drought stress, salt stress, stress induced by exposure to toxic elements, stress induced by exposure to heavy metals, oxidative stress, waterlogging stress, and / or nutrient deficiency stress.

32. A method of producing a plant having increased root suberin deposition, the method comprising introducing into the plant a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof as defined in any of claims 13 to 19.

33. The method of claim 32, wherein the polynucleotide encoding an SBG1 protein or homolog or ortholog thereof is introduced into the plant by direct gene transfer, microinjection, transformation and / or virus-mediated methods.

34. The method of claim 33, wherein the method of transformation is Agrobacterium tumefaciens-mediated transformation.

35. The method of any of claims 32 to 34, wherein the polynucleotide further comprises a promoter, optionally wherein the promoter is a heterologous promoter.

36. The method of any of claims 32 to 35, wherein the heterologous promoter is a constitutive promoter, a tissue-specific promoter or an inducible promoter.

37. The method of any of claims 32 to 36, wherein the constitutive promoter is UBQ10, or CaMV35S.

38. The method of any of claims 32 to 37, wherein the polynucleotide encodes an SBG1 protein or a homolog or ortholog thereof comprising an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28.

39. The method of claim 38, wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises the amino acid sequence of any of SEQ ID NOs: 1 or 8-28.

40. The method of any of claims 32 to 39, wherein the polynucleotide sequence comprises a nucleotide sequence having at least 60% sequence identity to any of SEQ ID NOs 2-7, optionally comprising a polynucleotide sequence selected from any of SEQ ID NOs: 2-4.

41. A method of introgressing a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof as defined in any of claims 13 to 19 into a plant, the method comprising:(i) crossing a first plant comprising a polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof with a second plant lacking a native polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof so as to produce a population of offspringcomprising said polynucleotide encoding an SBG1 protein or a homolog or ortholog thereof; and(ii) selecting offspring comprising the polynucleotide encoding said SBG1 protein or a homolog or ortholog thereof.

42. The method of claim 41, wherein the polynucleotide introgressed into the offspring further comprises a promoter, optionally wherein the promoter is heterologous promoter.

43. The method of claim 42, wherein the heterologous promoter is a constitutive promoter, a tissue-specific promoter, or an inducible promoter.

44. The method of claim 43, wherein the promoter is UBQ10 or CaMV35S.

45. The method of any of claims 41 to 44, wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises an amino acid sequence having at least 60% sequence identity to any of SEQ ID NOs: 1 or 8-28.

46. The method of any of claim 45, wherein the SBG1 protein or homolog or ortholog thereof encoded by the polynucleotide comprises the amino acid sequence of any of SEQ ID NOs: 1 or 8-28.

47. The method of any of claims 41 to 46, wherein the polynucleotide sequence comprises a polynucleotide sequence having at least 60% sequence identity to any of SEQ ID NOs 2-7, optionally comprising a polynucleotide sequence selected from any of SEQ ID NOs: 2-4.

48. A plant or plant cell obtainable by the method of any of claims 32 to 47.

49. The method or plant or plant cell of any preceding claim, wherein the plant is a monocotyledonous plant or a dicotyledonous plant.

50. The method or plant or plant cell of any preceding claim, wherein the plant is selected from the group consisting of Arabidopsis thaliana, Cucumis melo, Populus trichocarpa, Vitis vinifera, Solanum lycopersicum, Zea mays, Oryza sativa, Brachypodium distachyon, Lotus japonicus, Medicago truncatula, Glycine max, Cicer arietinum, Cucumis sativus, Hordeum vulgare, Beta vulgaris, Daucus carota, Oryza sativa, Selaginella moellendorffii, Taxus chinensis, Amborella trichopoda.